1. business and industrial
2. business operations
3. business plans

North American Congress
of Clinical Toxicology
Organized by the American Academy of Clinical Toxicology
New Orleans, LA • October 17-21, 2014
Sponsored By:
• American Academy of Clinical Toxicology
• American Association of Poison Control Centers
Collaborating Associations:
• American College of Medical Toxicology
• Asia Pacific Association of Medical Toxicology
• Canadian Association of Poison Control Centres
• European Association of Poisons Centres and Clinical Toxicologists
Conference
Schedule
Continued
Education
Next
Page
North American Congress of Clinical Toxicology 2014
Sheraton New Orleans
October 17-21
Sponsored by:
American Academy of Clinical Toxicology
American Association of Poison Control Centers
Collaborating Associations:
American College of Medical Toxicology
Canadian Association of Poison Control Centres
European Association of Poisons Centres and Clinical Toxicologists
Organized by:
American Academy of Clinical Toxicology and the American Association of Poison Control Centers
Meeting Chairs:
Karen Simone, PharmD, President-Elect, AACT, Chair
Jay Schauben, PharmD, President-Elect, AAPCC, Co-Chair
AACT Scientific Advisory Council:
Kennon Heard, MD, PhD, Chair
Reza Afshari, MD, MPH, MSc, PhD, APAMT President
Lewis Nelson, MD, ACMT Immediate Past-President
Jay Schauben, PharmD, AAPCC President-Elect
Martin Laliberté MD, CAPCC Vice President
Simon Thomas, BSc, MD, EAPCCT Past President
Mark Winter, PhD, ABAT Scientific Affairs Committee Chair
A special thank you for assistance from Chen-Chang Yang, MD, MPH, DrPH
Scientific Committee:
Kennon Heard, MD, PhD, Chair
Mark Kostic, MD
Robert Palmer, PhD
Jay Schauben, PharmD
Karen Simone, PharmD
Continuing Health Care Professional Education Committee:
Bryan Hayes, PharmD, Co-Chair
Kirk Cumpston, DO, Co-Chair
Abstract Selection Committee:
Ziad Kazzi, MD, MD, Chair
Mark Kostic , Co-Chair
Public Education Committee:
Alexa Steverson, MA
Wendy Stephan, MPH
Specialist in Poison Information Committee:
Lynn Ballentine, BSN
Kathleen Anderson, PharmD
Logistics:
Sandy Giffin, MS, RN
Finance:
Rutherfoord Rose, PharmD
New Orleans, LA
2014 NORTH AMERICAN CONGRESS OF CLINICAL TOXICOLOGY
October 17-21, 2014
Welcome to the North American Congress of Clinical Toxicology (NACCT). The American Academy of Clinical Toxicology
is pleased to be your host for the 2014 Congress in New Orleans, LA We hope that you find this a valuable educational
experience as well as an enjoyable visit to New Orleans. Please contact any of the host staff if you need assistance. The
Contemporary Forums staff is assisting the hosts. Their office is located on the 3rd Floor, Napoleon Foyer.
Continuing Education
If you have paid for CE credit, please remember to complete your online evaluations, attendance forms and print your
Continuing Education Certificate at the end of the Congress. If you have not paid for CE and would like to do so, please
stop by the congress registration desk at your earliest convenience.
NACCT will be utilizing CPE Monitor for tracking and reporting of all ACPE-accredited continuing pharmacy education
activities. Pharmacists are required to complete their e-profile at www.nabp.net in order to obtain their NABP e-Profile ID.
Please remember that you will need to submit the NABP e-profile ID and birth date to receive credit at this year's meeting.
Name badges must be worn at all times to enter the Symposiums, Exhibits and Poster Sessions. Out of
consideration to others, infants, children and spouses are not permitted in the sessions or refreshment areas.
ACMT Pre-Meeting Symposium: “At the precipice of quality healthcare: The role of the Toxicologist in enhancing
patient and medication safety” Registration/Check-In will be held on Friday, October 17, 7:00 - 8:00 a.m.
AACT Pre-Meting Symposium:” Critical Care Update for the Toxicologist” Registration/Check-In will be held on
Saturday October 18, 7:00 – 8:00 a.m.
NACCT 2014 Main Congress Registration/Check-In will be held on Saturday, October 18, 1:00 - 5:00 p.m. and Sunday
October 19, 6:30- 5:00 p.m.
RETRIEVING SPEAKER HANDOUTS:
Speaker handouts will become available starting October 8. Please check the site or Mobile App regularly as the handouts
will be updated regularly. Follow these instructions to obtain speaker handouts:
INFORMA CLINICAL TOXICOLOGY JOURNAL:
The hard bound Clintox Journal will not be distributed onsite. Please down load the PDF file of the abstracts before arriving
to the conference either via the electronic syllabus or the Mobile App.
Presenters
All presenters are asked to arrive in sufficient time for their presentation. Presenters who requested use of a computer
and/or LCD must bring their presentation to the Congress Registration Desk and provide the Contemporary
Forums staff with a thumb drive the day before their presentation.
Poster presenters should note the appropriate poster set-up times in the Congress schedule. Please remove your
poster within 30 minutes after your session to facilitate set-up for the next group.
Sponsorship:
Rutherfoord Rose, PharmD
Jay Schauben, PharmD
Karen Simone, PharmD
Previous
With appreciation to: Leigh DeLaTorre,
Contemporary Forums Staff and
Sarah Shiffert, Degnon Staff
Robert S. Hoffman, MD, President, AACT
Marsha Ford, MD, President AAPCC
Meals
Continental Breakfast is available for participants only Sunday – Tuesday 6:30 - 8:00 a.m. in the Napoleon Ballroom CD, 3rd
Floor. Beverages for mid-morning and afternoon breaks will be served in the exhibit/poster area, Napoleon Ballroom CD.
While a few selected sessions do include a meal, most congress participants will be on their own for lunch. Restaurant
listings are available in the registration area. Also, the hotel concierge/guest services will be happy to guide you to the
perfect restaurant.
Home
Next
KEYNOTE PRESENTATION AND BREAKFAST will be held on Sunday, October 19. Continental Breakfast will be served
from 7:30 – 8:30 a.m., with the Keynote Presentation beginning promptly at 7:30 a.m. in the Napoleon AB Ballroom.
The Keynote Speaker, Deborah Blum, is a Pulitzer Prize – winning science writer and a professor of journalism at
the University of Wisconsin. She has written five books – most recently, the Poisoner’s handbook: Murder and the
Birth of Forensic Medicine in Jazz Age New York.
OPENING RECEPTION
The Opening Reception will be held on Sunday, October 19, from 7:30 - 8:30 p.m. in the Armstrong Ballroom located on
the 8th. Anyone who is not registered for the Congress and who wishes to attend the Opening Reception, will be required to
pay a one-time $50.00 “Accompanying Person/Guest” fee.
ONLINE LIBRARY- To be sure you receive the speakers’ most current information, and to support environmental
responsibility, the recorded conference sessions and PowerPoint slides will be available to you online on a complimentary
basis. Your tuition includes access to the Online CE Library for the Pre-Meeting Symposium and all Main Congress
recorded sessions for which you registered.
The hosts and participants of NACCT gratefully acknowledge the contributions of the meeting Sponsors:
McNeil Consumer Healthcare
BTG International, Inc.
Nerium SkinCare, Inc
Cumberland Pharmaceuticals
CAE Healthcare delivers medical simulation and audiovisual solutions to hospitals, medical and nursing schools,
emergency responders and the military worldwide. CAE Healthcare recently released Lucina, the new childbirth
simulator and Replay™, our new audiovisual solution for debriefing. Visit
www.caehealthcare.com<http://www.caehealthcare.com> to learn about our advanced patient, imaging and
interventional simulators, including iStan® shown here at NACCT.
Approximately 3 weeks after the Congress you will receive an email notifying you that the actual presentations recorded at
the live conference, along with the synchronized PowerPoint slides, are available to access in the Online Library. Please
refer to “Online Library-Open 24/7!” in this Conference Guide for your log-in code and additional details about this valuable
educational resource. Digitell representatives are available on-site to answer your questions.
NACCT MOBILE APP
Download the NACCT Mobile App so you can stay current with real time conference updates and notifications. Visit your
providers App store to download the App using event code NACCT2014. You will find a complete schedule, abstracts,
speaker handouts and additional conference information.
Name Badge
We recycle, so please drop your plastic badge holder and lanyard in a designated box as you leave on your last day.
Messages & Participant Roster
The message board located near the Congress Registration Desk is available for messages and announcements and
includes the pre-registered participant list. Please check it for important updates.
Smoking Restrictions
It is the policy of The Sheraton Hotel that smoking is not permitted in the meeting rooms, around the Congress Registration
Desk, Exhibit/Poster space or refreshment break areas. Thank you for your cooperation.
Personal Belongings
Please be sure to take your jacket, tote bags, notebooks, etc. with you when leaving the meeting rooms for any extended
period of time. NACCT cannot assume responsibility for lost or stolen articles.
TOURIST INFORMATION
Tourist information is offered by the New Orleans Convention Bureau at www.neworleanscvb.com
Previous
Home
Next
2014 NACCT Abstract Reviewers
Submission Categories
1. Adverse Drug Event/Therapeutic
Misadventures
2. Basic Science/
Pharmacokinetics/Laboratory
3. Drug Abuse or Misuse/Alcohol
4. Education/Prevention
5. Natural Toxins/Dietary Supplements
6. Epidemiology of
Poisoning/Bioterrorism/Forensic
7. GI decontamination/Antidote
Use/Enhanced Elimination
8. Intentional Overdose (e.g., Suicide)
9. Medication Errors/Unintentional
Overdose/Pediatric
Previous
Name
Mark Mycyk
Cynthia Aaron
Jao Delgado
Luke Yip
Bruno Megarbane
Jennifer Lowry
Robert Palmer
Javier Waksman
Vik Bebarta
Richard Wang
Adam Rowden
Steve Aks
Paul Dargan
Kirk Cumpston
Steve Walsh
Lauren Schwartz
JoAnn Chambers
Elizabeth Scharman
Mingzohn Tsay
Kerry Schwarz
Barry Rumack
Margaret Thompson
Adam Algren
Brandon wills
Hugo Kupferschmidt
Rick Spiller
Dayne Laskey
David Juurlink
Daniel Cobaugh
John Benitez
Christine Stork
Louise Kao
Anthony Pizon
Jane Terris
Kennon Heard
Amy Zosel
Victor Tuckler
Dan Brooks
John Devlin
Donna Seger
Alan Woolf
Sam Stellpflug
Serge-Emile Simpson
Bryan Hayes
RJ Hoffman
2014 NACCT Abstract Reviewers
Submission Categories
10. Occupational/Environmental/Metals
11. Poison Control Management/Public
Health
12. (General/Other)
Name
Jeffrey Brent
Chris Tomaszewski
David Vearrier
Bruce Anderson
Kurt Kleinschmidt
Deborah Anderson
Lee Cantrell
Doug Borys
Maria Mercurio - Zappala
Jill Michels
Eric Lavonas
Marty Caravati
Kristine Nanagas
Michael Darracq
Laura Tormoehlen
Home
Next
ACMT Pre-Meeting Symposium, October 17, 2014
Waterbury Ballroom, 2
Conference
Schedule
Previous
nd
Floor, Sheraton New Orleans Hotel
At the Precipice of Quality Health Care:
The Role of the Toxicologist in Patient and Medication Safety
Organizers / Moderators:
Brenna Farmer, MD, FACMT; Silas Smith, MD; Luke Yip, MD, FACMT
8:00-8:15
Introduction
8:15-8:45
An Anesthesia Event: The Case for Patient Safety
Silas Smith, MD, Chief, Quality, Safety, and Practice Innovation, Assistant Professor, Department
of Emergency Medicine, New York University School of Medicine
8:45-9:30
Just Culture and Building a Culture of Safety
Robin Hemphill, MD, Veteran’s Health Affairs Chief Safety and Risk Management Officer, Director,
National Center for Patient Safety
9:30-9:45
BREAK
9:45-10:15
High Reliability Organizations and Patient Safety
Luke Yip, MD, FACMT, Denver Health, Rocky Mountain Poison and Drug Center, Department of
Medicine, Section of Medical Toxicology
10:15-11:00
The Institute for Safe Medication Practices' Efforts to Improve Medication Safety
Allen Vaida, Pharm D., Executive Vice President, Institute for Safe Medication Practices
11:00-11:30
The Food and Drug Administration’s Efforts to Improve Patient and Medication Safety
Keith Burkhart, MD, FACMT, Senior Advisor for Medical Toxicology, FDA Center for Drug
Evaluation and Research, Office of Translational Sciences, Office of Clinical Pharmacology
11:30-12:45
LUNCH - on your own
12:45-1:15
The Surveillance and Management of Medication Events Reported to Poison Control
Centers
Alfred Aleguas Jr., PharmD, DBAT, Managing Director, Florida Poison Information Center-Tampa
1:15-2:15
Communicating About Errors: The Role of Simulation
Brenna Farmer, MD, FACMT; Silas Smith, MD; Luke Yip, MD, FACMT
2:15-2:30
BREAK
2:30-3:00
Go Team! Innovative Approaches to Medication Safety
Brenna Farmer MD, FACMT, Director of Patient Safety, Weill-Cornell Medical Center, Division of
Emergency Medicine and Assistant Residency Director, NY Presbyterian Hospitals Emergency
Medicine Residency
3:00-3:45
Panel Discussion: Looking at Safety Through the Eyes of a Toxicologist
Panelists: Brenna Farmer, MD, FACMT; Silas Smith, MD; Luke Yip, MD, FACMT
3:45-4:30
Building a Career in Patient Safety
Moderator: Lewis S. Nelson, MD, FACMT, New York University School of Medicine
Panelists: Keith Burkhart, MD, FACMT, FDA Center for Drug Evaluation and Research; Erica
Liebelt, MD, FACMT, University of Alabama School of Medicine; Jeanmarie Peronne, MD,
FACMT, University of Pennsylvania Perelman School of Medicine; Luke Yip, MD, FACMT, Rocky
Mountain Poison and Drug Center
Home
Next
14:10 – 14:45 Optimal use of Sedation for the Poisoned Patient in the ICU
Katherine Jennings, PharmD, Clinical Pharmacist, Neurocritical Care, Ochsner Medical Center
AACT Pre-Meeting Symposium:
Critical Care Update for the Toxicologist
Saturday, October 18, 2014, Napoleon Ballroom A/B, 3rd Floor, Sheraton New Orleans Hotel
Organizer: Kennon Heard, MD, PhD
Moderators: Tammi Schaeffer, DO & Robert Palmer, PhD
14:45 – 15:00 BREAK
15:00 – 15:35 Management of Acute Liver Failure due to Poisoning
Peter DeBlieux, MD Professor of Clinical Medicine, Section of Emergency Medicine
Louisiana State University School of Medicine
7:55 – 8:00
Introduction and Opening Remarks
15:35 – 16:10 Refusal of Care, Decisional Capacity and Organ Donation: Ethics and the Poisoned Patient
Jean Abbott, MD, MH Professor Emerita, Emergency Medicine, Faculty, Center for Bioethics &
Humanities, University of Colorado School of Medicine
8:00 – 8:35
Ventilator Management and Non-Invasive Ventilation for the Poisoned Patient
Samantha Wood, MD, Assistant Professor of Emergency Medicine, Tufts University School of Medicine
Attending Physician, Department of Emergency Medicine, Maine Medical Center
16:10 – 16:45 Special issues in the ICU Management of the Poisoned Child
Constantine Dimitriades, MD, Associate Professor of Pediatrics
Medical Director, Pediatric Intensive Care Unit, Louisiana State University Health Sciences Center
8:35 – 9:10
Pharmacologic Management of Hypotension in the Poisoned Patient
Kristin Engebretsen, PharmD Clinical Toxicologist, Regions Hospital, Clinical Associate Professor,
University of Minnesota College of Pharmacy
16:45 – 17:00 Panel Discussion (Afternoon Session) and Closing Remarks
9:10 – 9:45
Extracorporeal Support: The Ultimate Rescue Therapy for the Poisoned Patient
Norman Paradis, MD Director of Research – Emergency Medicine, Professor of Medicine
Geisel School of Medicine at Dartmouth
9:45 – 10:00
BREAK
10:00 – 10:35 Preventing In-Hospital Complications: Prophylactic Measures for the Poisoned Patient in the ICU
Scott Phillips, MD Associate Clinical Professor of Medicine, University of Colorado School of Medicine
Rocky Mountain Poison & Drug Center; Newfields Impact Assessment Services
10:35 – 11:10 Update on HBO in Toxicology: CO and H2O2
Christian Tomaszewski, MD Medical Toxicologist & Hyperbaric Physician; Medical Director, Department
of Emergency Medicine; Professor of Clinical Emergency Medicine, UC San Diego School of Medicine
11:10 – 11:45 Renal Replacement Therapies in the Poisoned Patient
Darren Roberts, MBBS, PhD, Staff Specialist, Drug Health Clinical Services, Royal Prince Alfred Hospital
Honorary Senior Fellow, Burns Trauma and Critical Care Research Centre
School of Medicine, University of Queensland
11:45 – 12:00 Panel Discussion (Morning Session Speakers)
12:00 – 13:00 Lunch – On your own
13:00 – 13:35 New Technology for Monitoring the Poisoned Patient
Matt Zuckerman, MD Assistant Professor, Department of Emergency Medicine
University of Massachusetts
13:35 – 14:10 Beyond Benzos: New Millennium Directions in the ICU Treatment of Ethanol Withdrawal
Mark Mycyk, MD, Research Director, Toxikon Consortium
Associate Professor, Northwestern University Feinberg School of Medicine
Previous
Home
Next
Friday, October 17, 2014
Conference Schedule
7:00 am – 5:00 pm
Napoleon Foyer
3rd Floor
ACMT Pre-Symposium: Registration/Information
7:00 am – 8:00 am
Napoleon Foyer
3rd Floor
Continental Breakfast
8:00 am – 4:30 pm
Waterbury Ballroom
2nd Floor
ACMT Symposium: At the Precipice of Quality Health Care;
The Role of the Toxicologist in Patient and
Medication Safety
Moderators: Lewis Nelson MD,FACMT
Silas W. Smith, MD, FACEP
Luke Yip, MD, FACMT
Presentations:
The Case for Patient Safety
Silas W. Smith, MD, FACEP
Just Culture and Building a Culture of Safety
Robin Hemphill, MD
High Reliability Organizations and Patient Safety
Luke Yip, MD, FACMT
The Institute for Safe Medication Practices’ Efforts to
Improve Medication Safety
Allen Vaida, PharmD
The Food and Drug Administration’s Efforts to Improve
Medication Safety
Keith Burkhart, MD, FACMT
.
Previous
Friday, October 17, 2014, continued
Conference Schedule
The Surveillance and Management of Medication Events
Reported to Poison Control Centers
Alfred Aleguas Jr., BS, PharmD, DABAT
Communicating about Errors: The Role of Simulation
Brenna Farmer, MD, Silas W. Smith, MD, FACEP
Luke Yip, MD, FACMT
Go Team! Innovative Approaches to Medication Safety
Brenna Farmer, MD, FACMT
Panel Discussion: Looking at Safety through the Eyes of a
Toxicologist
Brenna Farmer, MD, FACMT, Silas W. Smith, MD, FACEP,
Luke Yip, MD, FACMT
Building a Career in Patient Safety
Moderator: Lewis S. Nelson, MD, FACMT
Panel Discussion:
Keith Burkhart, MD, FACMT, Erica Lielbelt, MD, FACMT,
Jeanmarie Peronne, MD, FACMT
At the end of this session, the participant should be able to:
1. Describe how an anesthesia event led to systemic response to improve patient and
medication safety..
2. Define and describe the concept of Just Culture.
3. Define the difference between human error, at risk behavior, and reckless behavior
in a Just Culture.
4. Define high reliability organizations/industries.
5. Understand how Crew Resource Management concepts (i.e. checklists and sterile
cockpit) apply to medication and patient safety in all clinical settings.
6. Understand ISMP's organization and mission to improve medication safety.
7. Describe how ISMP investigates medication errors and adverse drug events.
8. Describe how ISMP creates their recommendations for medication management
best practices and distributes them.
9. Describe some FDA efforts to improve medication safety throughout the drug life
cycle from an IND (Investigational New Drug), through an NDA (New Drug
Application) and then post -market pharmacovigilance.
Home
Next
Friday, October 17, 2014, continued
Conference Schedule
Friday,
October 17, 2014
Rooms
10. Describe databases and tools used at the FDA to enhance medication safety.
11. Discuss the surveillance of medication events by Poison Control Centers.
12. Discuss how Poison control Centers can assess and manage medication events.
13. Apply specific communication techniques in difficult conversations when giving
recommendations for treatment related to medication errors.
14. Describe how multidisciplinary teams can improve medication safety.
15. Describe how safety rounds in clinical areas can improve medication safety.
16. Understand and apply patient safety concepts as they apply to actual medication
events.
17. Discuss different approaches to starting a career in patient safety.
8:00 am – 5:00 pm
Nottoway 4th floor
AACT Board Meeting
12:00 am – 3:00 pm
Edgewood 4th floor
International Workgroup CCB Guidelines
12:00 pm – 6:00 pm
Esterwood 4th floor
ABAT Exam (Part 1)
5:00 pm – 9:00pm
Edgewood 4th floor
ABAT Board Meeting (Part 1)
Saturday, October 18, 2014
700am
730am
800am
830am
900am
930am
Napoleon Foyer
3rd Floor
1000am
1030am
1100am
1130am
1200pm
1230pm
100pm
130pm
200pm
230pm
300pm
330pm
400pm
430pm
500pm
530pm
600pm
630pm
700pm
730pm
800pm
830pm
900pm
ACMT Pre-Symposium Registration/Continental Breakfast
Waterbury
Ballroom 2rd
Floor
ACMT Symposium- At the precipice of quality heath care: The Role of the Toxicologist in Patient and Medication Safety
Edgewood 4th
Floor
International Workgroup CCB Guideline
Nottoway 4th
Floor
ABAT Board Meeting (Part 1)
AACT Board Meeting
Esterwood 4th
Floor
ABAT Exam (Part 1)
Color Key
Main
Symposi AAPCC
a
ACMT
AACT
ABAT
MISC
Private
Conference Schedule
7:00 am – 1:00 pm
Napoleon Foyer AB
3rd floor
ACCT Pre-Meeting Symposium:
Registration/Continental Breakfast
8:00 am – 5:00 pm
Napoleon Ballroom AB
3rd floor
AACT Symposium: Critical Care Update for the
Toxicologist
Moderators: Tammi Schaeffer, DO
Robert Palmer, PhD, DABAT, FAACT
Presentations:
Ventilator Management and Non-Invasive Ventilation for
the Poisoned Patient
Samantha Wood, MD
Previous
Home
Next
Saturday, October 18, 2014, continued
Conference Schedule
Pharmacologic Management of Hypotension in the
Poisoned Patient
Kristin Engebretsen, PharmD
Extracorporeal Support: The Ultimate Rescue Therapy for
the Poisoned Patient
Norman Paradis, MD
Preventing In-Hospital Complications: Prophylactic
Measures for The Poisoned Patient in the ICU
Scott Phillips, MD
Update on HBO in Toxicology: CO and H 2 O 2
Christian Tomaszewski, MD, MS
Renal Replacement Therapies in the Poisoned Patient
Darren Roberts, MBBS, PhD
New Technology for Monitoring the Poisoned Patient
Matt Zuckerman, MD
Benzos: New Millennium Directions in ICU Treatment of
Ethanol Beyond Withdrawal
Mark Mycyk, MD
Conference Schedule
At the end of this session, the participant should be able to:
1. Apply ventilator management and non-invasive ventilation strategies to the poisoned
patient.
2. Describe the use of adrenergic vasopressors in CV poisoned patients.
3. Describe the use of extracorporeal support in the care of poisoned patients and
review of possible indications and practicalities of emergent applications.
4. Recognize and prevent in-hospital complications in poisoned patients in the ICU.
5. Relate current literature on HBO for treatment of patients poisoned with CO and
H2O2.
6. Describe the various methods of renal replacement therapy and list considerations
when using these techniques in poisoned patients.
7. Explain the use of new technologies in the management of poisoned patients.
8. Understand the pathophysiology and best pharmacologic practice in the ICU
management of ethanol withdrawal.
9. Describe best sedation practices and use delirium assessment tools.
10. Describe recent advances in critical care management for liver failure.
11. Use a competency assessment tool and list the issues surrounding organ donation
and refusal of care.
12. List recommended interventions for poisoned pediatric patients in the ICU.
8:00 am – 1:00 pm
Esterwood 4th floor
ABAT Exam (Part 2)
8:00 am- 5:00 pm
Oak Alley 4th floor
ACMT Board of Directors Meeting
ABAT Board Meeting (Part 2)
Refusal of Care, Decisional Capacity and Organ Donation:
Ethics and the Poisoned Patient
Jean Abbott, MD, MH
9:00 am – 4:00 pm
Edgewood 4th floor
11:30 am – 5:00 pm
Nottoway 4th floor
AAPCC Board Meeting (Part 1)
Special Issues in the ICU Management of the Poisoned
Child
Constantine Dimitriades, MD
1:00 pm – 5:00 pm
Napoleon Foyer
3rd floor
NACCT Conference Registration/Information
1:00 pm – 5:15 pm
Napoleon Ballroom CD
3rd floor
Exhibitor Set Up/Poster #17-107 & 237-238
Optimal use of sedation for the poisoned patient in the ICU
Katherine Jennings, PharmD
Management of Acute Liver Failure Due to Poisoning
Peter Deblieax, MD
Previous
Saturday, October 18, 2014, continued
Home
Next
Saturday, October 18, 2014, continued
1:00 pm – 2:00 pm
Gallier A 4th floor
2:00 pm – 4:00 pm
Gallier A 4th floor
2:30 pm – 3:30 pm
Off Site
Conference Schedule
AACT Scientific Review Committee
Lipid Emulsion Group
Saturday,
October 18, 2014
Rooms
Napoleon Foyer
3rd Floor
700am 730am 800am
830am
900am
1000am
1030am 1100am 1130am
1200pm
1230pm 100pm
130pm
AACT Pre-Symposium Registration/Continental Breakfast
Napoleon
Ballroom AB
3rd Floor
200pm
230pm
300pm
PEC Educator Meet and Greet
Moderators: Alexa Steverson, MA
Wendy Stephan, MPH, CHES
5:00 pm – 9:30 pm
Southdown 4th floor
SPI Committee
5:00 pm – 10:00 pm
Edgewood 4th floor
AAPCC Accreditation Meeting
5:15 pm – 7:15 pm
Napoleon Ballroom AB
3rd floor
ACMT Medical Toxicology 16th Annual Clinical
Pathophysiology Competition (CPC)
Moderator: Jeffrey R. Suchard, MD, FACMT, FACEP
400pm
430pm
4:45pm
Napoleon
Ballroom CD
3rd Floor
500pm
5:15pm
530pm
600pm
6:15pm
630pm
700pm
7:15pm
730pm
7:45p
8:15p
800pm
830pm
m
m
8:45pm
900pm
930pm
NACCT Conference Registration
ACMT Medical Toxicology 16th Annual
Clinical Pathophysiology Competition (CPC)
Exhibitor Set Up /Poster Session I Set - Up Poster # 17-107 & 237-238
( Posters # 98-100 will present on day 2)
Edgewood 4th
Floor
ABAT Board Meeting (Part 2)
AAPCC Accreditation Meeting
ABAT Exam (Part 2)
Off Site
AACT Scientific
Review
Committee
Gallier A 4th
Floor
PEC: New
Orleans
Pharmacy
Museum Tour
Lipid Emulsion Group
PEC Educator Meet &
Greet
PEC Opening
Meeting/ Committee
Reports
Borgne 3rd
Floor
5:00 pm – 6:00 pm
Gallier A 4th floor
330pm
AACT Symposium: Critical Care Update for the Toxicologist
Esterwood 4th
floor
PEC: New Orleans Pharmacy Museum Tour
930am
Nottoway 4th
Floor
AAPCC Board Meeting (Part 1)
Southdown 4th
Floor
PEC Joint Steering
Committee Meeting
AAPCC NPDS Steering Comm
SPI Committee
Waterbury
Ballroom 2nd
Floor
AACT
Business
Meeting
Oak Alley 4th
Floor
ACMT Board of Directors Meeting
Main
Color
Sympo AAPCC
Key
sia
ACMT
AACT
ABAT PEC
MISC
AACT Fellows Reception
AAPCC
Benchmarking/QA
Private
At the end of the session, the participant should be able to:
1. Formulate an approach to the diagnosis of complex poisoning cases based on
limited data.
2. Describe the management of several unique poisonings.
3. Identify potential pitfalls in the diagnostic approach to poisoned patients.
Previous
Home
Next
Saturday, October 18, 2014, continued
Conference Schedule
Sunday, October 19, 2014, continued
Conference Schedule
5:30 pm - -7:00 pm
Nottoway 4th floor
AAPCC NPDS Steering Committee
6:00 pm – 7:00 pm
Borgne 3rd floor
PEC Opening Meeting/Committee Reports
Presenters: Tammy Noble, RN, BSN, CSPI
Kristin Wenger, MAT
7:00 pm – 7:45 pm
Borgne 3rd floor
PEC Joint Steering Committee Meeting
Presenters: Kristin Wenger, MAT
Alexa Stevenson, MA
7:00 pm – 7:45 pm
Oak Alley 4th floor
AAPCC Benchmarking/Q&A
7:15 pm – 7:45 pm
Waterbury Ballroom
2nd floor
AACT Business Meeting
8:30 am – 9:00 am
Borgne 3rd floor
PEC News/Events
Presenter: Kristin Wendger, MAT
Alexa Steverson, MA
7:45 pm – 8:45 pm
Waterbury Ballroom
2nd floor
AACT Reception with Induction of New Fellows and Career
Achievement/Distinguished Service Recognition Awards
8:30 am – 9:30 am
Napoleon Ballroom AB
3rd floor
ACMT Ellenhorn Lecture: Whole Bowel
Irrigation: Conception, Development, Acceptance and
Application
Moderator: Suzanne White, MD, MBA, FACMT
Presenter: Milton Tenenbein
MD, FRCPC, FAAP, FAACT, FACMT
Moderator: Robert S. Hoffman,
MD, FAACT, FACMT, FRCP, (Edin)
Sunday, October 19, 2014
Conference Schedule
6:30 am – 5:00 pm
Napoleon Foyer
3rd floor
NACCT Main Congress: Registration/Information
6:30 am – 8:00 am
Napoleon Ballroom CD
3rd floor
Continental Breakfast
7:00 am – 4:00 pm
Napoleon Ballroom CD
3rd floor
Exhibits/Abstracts #17-107 & 237-238
Previous
7:00 am – 8:00 am
Gallier
4th floor
ACCPCC Surveillance Team
7:30 am – 8:30 am
Napoleon Ballroom AB
3rd Floor
NACCT Keynote Presentation: The (Sometimes Poisonous)
Chemistry of Communication
Moderator: Bryan Judge, MD
Presenter: Deborah Blum
At the end of the session, the participant should be able to:
1. To review major events in the development of forensic toxicology.
2. To provide examples of effective communication of scientific findings to the general
public.
At the end of the session, the participant should be able to:
1.
2.
3.
4.
State the initial application of WBI.
Trace the research and development of WBI.
Cite the acceptance of WBI.
Discuss the indications for WBI.
Home
Next
Sunday, October 19, 2014, continued
8:30 am – 10:30 am
Maurepas 3rd floor
Conference Schedule
Sunday, October 19, 2014, continued
How to Teach Tox SIMS: No More Death by PowerPoint!
Using High Fidelity Case Based Simulation to Teach
Toxicology - Theory to Delivery
Clinical toxicology of recently emerging Novel
Psychoactive Substances (NPS)
David Wood, MD
Organizer: Tammi Schaeffer, DO
Presenter: Jeffrey Holmes, MD
Improving international arrangements for toxicovigilance
to counter the health threats posed by NPS
Irma DeVries, MD, FAACT
At the end of the session, the participant should be able to:
1. Describe why simulation is different than traditional didactic learning.
2. Demonstrate how to use instructional systems design to create simulation
curriculum.
3. Explain why teaching objectives are so important in scenario design.
4. Demonstrate how to create effective teaching objectives.
5. Describe the core components of a well written simulation case.
6. Describe how to write and deliver effective high fidelity simulation cases.
9:00 am – 9:30 am
Borgne 3rd floor
PEC: AAPPC Updates
Presenter: Krista Osterthaler, MPH
At the end of the session, the participant should be able to:
1. Outline key projects and activities that AAPCC has undertaken on behalf of poison
centers.
2. Identify projects that may be helpful on the individual poison center level.
9:00 am – 5:00 pm
Napoleon Foyer
toxiCall® Training
9:30 am – 10:30 am
Napoleon Ballroom AB
3rd floor
Authors with Posters: #17-107 & 237-238
10:30 am – 12:30 am
Napoleon Ballroom AB
3rd floor
EAPCCT Symposium: New Recreational drugs of abuseDevelopments in Europe and North America. How can we
Improve collaborations to detect these sooner?
Moderator: Simon Thomas, MD, FRCP
Presenters:
Pharmacology and mechanisms of toxicity of Novel
Psychoactive Substances
Bruno Megarbane, MD
Clinical toxicology of recently emerging Novel
Psychoactive Substances (NPS)
Previous
Conference Schedule
At the end of the session, the participant should be able to:
1. Classify novel psychoactive substances (NPS) according to chemical group and
pharmacological actions toxicological effects.
2. Discriminate between different classes of NPS on the basis of toxicological effects.
3. Formulate appropriate clinical management plans for patients presenting with toxicity
after use of NPS.
4. Summarize the mechanisms of toxicovigilance currently used internationally to
identify emerging NPS and characterize their clinical toxicology.
5. Describe how international arrangements could be improved to collect information
more effectively and to counter the health threats posed by NPS.
10:30 am – 11:30
Gallier A 4th floor
AACT Herbs and Dietary Supplement SIG
10:30 am – 11:30
Nottoway 4th floor
AACT Occupational/Environmental SIG
10:30 am – 11:30
Borgne
3rd floor
PEC: A Harm Reduction Approach to Injury Prevention:
Naloxone Rescue Kits in the Community
Presenter: Tessie Castillo, BA
At the end of the session, the participant should be able to:
1. Understand what a “Good Samaritan Law” is and which states have passed Good
Samaritan Laws.
2. Review the proper routes of administration of naloxone for acute opioid overdose.
3. Discuss one state's implementation of harm reduction in communities to reduce and
counteract overdoses with the use of Naloxone Rescue Kits.
11:30 am – 12:30
Gallier 4th floor
AACT Toxicological History SIG
Home
Next
Sunday, October 19, 2014, continued
11:30 am – 12:30
Borgne 3rd Floor
Conference Schedule
PEC: Poison Myth vs Fact: Internet, Folklore, and Other
Remedies
Presenter: Jill Michels, PharmD
At the end of the session, the participant should be able to:
1. Identify at least two commonly held misconceptions about treating poisonings
2. Review the proper, evidence-based treatment recommendations for common
poisonings in which the public has shown a lack of awareness
3. Examine the implications of Internet triaging on the self-management of poisonings
11:30 am – 12:30
Bayside A 4th floor
AAPCC Medical Directors
12:30 am – 1:30 pm
Lunch On Own
12:30 am – 2:00 pm
Nottoway 4th floor
Informa Editorial Board Luncheon
12:30 am – 1:30 pm
Oak Alley 3rd floor
JMT Editorial Board Meeting
12:30 am – 1:30 pm
Southdown 4th floor
ACMT Focus Group Luncheon
1:30 pm – 2:30 pm
Borgne 3rd Floor
PEC: When the Water Isn't Safe to Drink: Inside the West
Virginia Water Crisis
Presenter: Carissa McBurney, MPA
At the end of the session, the participant should be able to:
1.
2.
3.
4.
Previous
Define the nature and scope of the West Virginia water contamination crisis.
Address how poison centers are equipped to handle a crisis event.
Address crisis communication strategies used during the event.
Evaluate how poison centers can emerge as expert responders for the public and
healthcare providers during and post such emergencies.
Sunday, October 19, 2014, continued
1:30 pm – 3:30 pm
Napoleon Ballroom AB
3rd floor
Conference Schedule
Platform 1 #1-8
Moderators: Andrew Stolbach, MD, FACMT
Suzanne White MD, MBA, FACMT
1. Prescription stimulants and hospitalization for psychosis: A case-crossover study
A M Cressman3, E Macdonald1, A N Huang1, T Gomes1, J M Paterson1, P A Kurdyak1, M
N Mamdani2, D N Juurlink1 1Institute for Clinical Evaluative Sciences, Toronto ON Canada;
2Li Ka Shing Knowledge Institute, Toronto ON Canada; 3University of Toronto, Toronto ON
Canada
2.Mitochondrial dysfunction produced by diglycolic acid, the nephrotoxic metabolite
of diethylene glycol T Conrad, T Y Aw, K E McMartin LSU Health Sciences Center,
Shreveport LA USA
3.Serum acetaminophen-protein adduct concentrations in pediatric patients
V E Anderson, K Heard, E J Lavonas, R C Dart, J L Green
Rocky Mountain Poison & Drug Center – Denver Health, Denver CO USA
4. Positive association between ondansetron and significant cardiac events in adult
and elderly hospitalized patients M Zhang1, A Szabo1, D D Gummin2, A E Zosel2
1Medical College of Wisconsin, Milwaukee WI USA; 2Wisconsin Poison Center, Milwaukee
WI USA
5. Geographic information systems of influenza-like illness (ILI) based on
medications: Relating National Poison Data System (NPDS) exposure data to CDC
reporting of ILI G A Beauchamp, N J McKeown, D A Spyker Oregon Health & Science
University, Portland OR USA
6. Poison Center Surge Capacity E J Scharman West Virginia Poison Center, Charleston
WV USA
7. Human effects of 4-methylcyclohexanemethanol E J Scharman, A F Pizon
West Virginia Poison Center, Charleston WV USA
8. Impact of time on market & prevention strategies on accidental childhood
exposures to single use laundry detergent packs J Colvin1, S Yin1, A Behrman1, L
Rylander2, K Vasunia2 1Cincinnati Drug & Poison Information Center, Cincinnati OH USA;
2Procter & Gamble, Cincinnati OH USA
Home
Next
Sunday, October 19, 2014 , continued
Conference Schedule
At the end of the session, the participant should be able to:
1. Discuss the possible association between prescription stimulant therapy and new
onset psychosis.
2. Discuss the possible mechanisms of toxicity from diethylene glycol.
3. Describe the levels of protein adducts in pediatric acetaminophen toxicity.
4. Discuss the possible association between the use of ondansetron and cardiac
adverse events.
5. Describe the use of NPDS data for influenza-illness surveillance.
6. Describe a regional poison center response to a chemical contamination of a water
source.
7. List the clinical effects reported to a regional poison center after a chemical water
contamination event.
8. Describe the effect of marketing strategies on pediatric exposures to laundry pod
detergents.
2:30 pm – 3:30 pm
Borgne 3rd floor
PEC: The Art of Presentation: How to Address Education
Barriers and Audience Segmentation (Part 1)
Moderator: Alexa Steverson, MS
Presenters: Jennifer Watson, BS
ChariseThomason, MPH
Mike Yudizky, BS
At the end of the session, the participant should be able to:
1. Recognize emerging poison issues in the news and in your community.
2. Use appropriate research methods to collect accurate and timely information on new
poison threats.
3:30 pm – 4:15 pm
Gallier A 4th floor
ACMT Addiction Medicine Section
3:30 pm – 4:15 pm
Oak Alley 3rd floor
ACMT Medication Management Section
3:30 pm – 4:15 pm
Southdown 4th floor
ACMT Government Section
3:30 pm – 4:30 pm
Nottoway 4th floor
AACT Envenomation SIG
4:00 pm – 5:00 pm
Napoleon Ballroom CD
3rd floor
Poster Session I Tear Down #17-107 and 237-238
Previous
Sunday, October 19, 2014, continued
4:15 pm - 5:15 pm
Napoleon Ballroom AB
3rd floor
Conference Schedule
ACMT Practice Symposium: The Creation
and Preservation of a Medical Toxicology Service
Moderator: Ayrn O’Connor, MD
Presenters:
Effects of a Medical Toxicology Admitting Service on
Length of Stay, Cost of Care and Mortality Among
Poisoned Patients
Daniel Brooks, MD
Utilization of Observation Units for the Care of Medical
Toxicology Patients: Emerging Trends and Perspectives
from a Private Medical Toxicology Service
Bryan Judge, MD
At the end of the session the participant should be able to:
1. Review methods of a study performed in which length of stay, cost (using the cost to
charge ratio) and mortality were compared for patients cared for by toxicologists,
non-toxicologists hospitalists in the same medical center, and non-toxicologist
hospitalists at other hospitals within the same healthcare system.
2. Summarize the impact that toxicologists had on expected length of stay, cost and
mortality.
3. Discuss how such a study is beneficial in establishing and maintaining a subspecialty service. Identify how this study may be replicated in other clinical settings.
4. Discuss the emerging trends regarding the types of medical toxicology patients
cared for in observation units; highlighting key elements of appropriate patient
selection.
5. Explain how an observation unit can be utilized to optimize care of patients on the
medical toxicology service and discuss the functional requirements of the
observation unit.
6. Apply the principles learned in establishing an observation unit that cares for
toxicology patients.
4:15 pm - 5:15 pm
Waterbury Ballroom
2nd floor
ABAT Symposium: Clinically Relevant Herb-Drug
Interactions: Past, Present, Future
Moderators: Mark Winter, PhD, DABAT, FAACT
Alfred Aleguas, Jr. BS, PharmD, DABAT
Presenter:
Phytochemical modulation of human drug metabolism: an
introduction to clinically relevant herb-drug interactions
Billy Gurley Jr., PhD
Home
Next
Sunday, October 19, 2014, continued
Conference Schedule
At the end of the session, the participant should be able to:
1. State the prevalence of dietary supplement usage in the U.S.
2. Recognize the potential for botanical supplements to interact with conventional
medications.
3. Provide examples of clinically relevant herb-drug interactions.
4. Describe clinical evidence that other commonly used botanical supplements can
modulate drug metabolizing enzyme and / or transporter activity and thus produce
herb-drug interactions.
Sunday,
October 19, 2014
Rooms
700am 730am
800 am
815am
PEC: Poisons in Pop Culture VI: 2014 NACCT Team Trivia
Moderators: Donna Lotzer, RPh, SPI
Tammy Noble, Rn, BSN, CSPI
JoAnn Chambers-Emerson, RN, BSN, CSPI
Presenter: JoAnn Chambers-Emerson, RN, BSN, CSPI
At the end of the session, the participant should be able to:
1. State benefits of using game show format in education outreach.
2. Recall events in 2013-2014 news stories involving poisonings and public health.
3. Participate in a method of using news stories to provide accurate toxicology
information.
4. Identify interventions by poison centers or health educators cited in 2013-2014
publications.
5. Describe Turing Point Technology usage for interactive programs.
6. Participate in teams with SPIs, managers and medical directors.
4:30 pm - 5:30 pm
Gallier A 4th floor
AACT Pediatric SIG
5:00 pm – 6:00 pm
Napoleon Ballroom CD
3rd floor
Poster Session II Set Up Abstracts #108-199 and 98-100
5:15 pm – 6:15 pm
Bayside C 4th floor
ACMT Fellows-in-Training Roundtable Symposium:
Evaluation of Job Options
Moderator: Jeffrey Brent, MD, PhD
900am
930am 1000am
Napoleon Foyer 3rd
Floor
Napoleon Ballroom
CD 3rd Floor
Napoleon Ballroom
AB 3rd Floor
1030am
1100am
1130am
1200pm
1230pm
100pm
130pm
200p
m
230pm
300pm
330pm
400pm
4:15pm
430pm
500pm
5:15p
530pm 600pm 6:15pm 630pm
700pm
730pm
800p
830pm 900pm
m
NACCT Main Congress Registration/Information
Continental Breakfast 6:30-8:00 /Exhibits / Authors with Posters 9:30 to 10:30/Posters #17-107 and 237-238 ( Posters 98-100 will present on day 2)
Keynote
Presentation: The
(Sometimtes
Poisonous)
Chemistry of
Communication
ACMT Ellenhorn
Lecture: Whole
EAPCCT Symposium: New recreational
Bowel
drugs of abuse - Developments in
Irrigation:Concept Break AWP Europe and North America. How can we
ion, Development,
improve collaborations to detect these
Acceptance and
sooner?
Application
Waterbury
Ballroom 2nd Floor
Lunch
Platform I/Abstracts #1-8
e Team
AACT Occ
/EnvSig
Nottoway 4th Floor
Break
ACMT
Addiction Med.
Section
Lunch
Isn't Safe to
Drink:
Inside the
West
The Art of
Presentation
Part 1
Break
JMT Editorial
Board
ACMT Med
Management
Section
Southdown 4th
Floor
ACMT Focus
Group lunch
ACMT
Government
Section
AAPCC Medical
Directors
AAPCC SPI Awards/ Quiz Bowl
AACT
Pediatric SIG
AACT Envenomation
SIG
Oak Alley 3rd Floor
Bayside A 4th Floor
ACMT Practice
Symposium: The
Creation and
Preservation of a
Medical Toxicology
Service
y p
Clinically Relevant
Herb-Drug
Interactions: Past,
Informa Editorial Board
Lunch
Reduction
PEC: Poison Myth
PEC
Approach to
PEC
vs. Fact: Internet,
News/ AAPCC Break AWP Injury Prevention:
Folklore and Other
Naloxone Rescue
Events Updates
Remedies
Kits in the
Poster Session I Tear Poster Session II Set
Down # 17-107 & 237- up Abstracts # 108199 & 98-100
238
BTG
Sponsored
Lunch
AACT
AACT
Herbs & Dietary Toxicological History
SIG
Supplement SIG
AAPCC
Gallier A 4th Floor Surveillanc
Borgne 3rd Floor
4:15 pm - 5:15 pm
Borgne 3rd floor
830am
PEC: Poisons in Pop
Culture VI
ACMT Fellowship
Directors Committee
ACMT Practice Committee
Bayside B 4th Floor
ACMT FIT
Roundtable
Symposium
Bayside C 4th Floor
NACCT
Opening
Reception
Armstrong
Ballroom 8th Floor
NACCT Sponsor
Reception
Grand Couteau 5th
Floor
Napoleon Foyer 3rd
Floor
toxiCall® Training
How to Teach TOX SIMS
Maurepas 3rd Floor
Main
Color
Sympos AAPCC
Key
ia
ACMT
AACT
ABAT PEC
MISC Private
Panelist:
Joseph Rasimas, MD, PhD
Paul Wax, MD, FACMT
Previous
Home
Next
Sunday, October 19, 2014, continued
Conference Schedule
At the end of the session, the participant should be able to:
1. 1 .Critically evaluate medical toxicology position advertisements.
2. Decide the degree to which professional opportunities align with their own
aspirations.
3. Understand the factors that Department Chairs take into consideration when offering
4. positions to medical toxicologists.
5:15 pm - 6:30 pm
Bayside A 4th floor
ACMT Fellowship Directors Committee
5:15 pm - 6:30 pm
Bayside B 4th floor
ACMT Practice Committee
5:15 pm – 7:30 pm
Napoleon Ballroom AB
3rd floor
AAPCC SPI Awards/Quiz Bowl
Moderator: Prashant Joshi, MD
6:00 pm – 7:30 pm
Grand Couteau 5th floor
NACCT Sponsors Reception
7:30 pm – 8:30 pm
Armstrong Ballroom
8th floor
NACCT Opening Reception
Monday, October 20, 2014
7:30 am – 5:00 pm
Foyer 3rd floor
7:30 am – 9:00 am
Napoleon AB
3rd floor
Conference Schedule
AAPCC/CDC Joint Symposium: Utilizing PCC Data for
Public Health Surveillance
Moderator: Jay L. Schauben, PharmD, DABAT, FAACT
Presenters:
CDC's Surveillance and Response Activities using
the National Poison Data System (NPDS)
Royal Law, MPH
Developing and Implementing Analytic Methods for
Enhanced Toxicosurveillance
Howard Burkom, PhD
Smarter Medicine through Health Analytics
Jason Burke, BS, MS
At the end of the session, the participant should be able to:
Conference Schedule
NACCT Main Congress Registration/Information
6:30 am – 8:00 am
Continental Breakfast
Napoleaon Ballroom CD
3rd floor
7:00 am – 4:00 pm
Napoleon Ballroom CD
3rd floor
Exhibits/Abstracts #108-199 & 98-100
7:30 am – 8:30 am
817/821 8th floor
AAPCC Review Team Meeting
Previous
Monday, October 20, 2014, continued
1. Describe the current status and methodology for use of poison center data for public
health surveillance.
2. Describe dimensions of situational awareness possible in toxicosurveillance
methodology.
3. Discuss how standard and ad hoc case definitions can contribute to a robust alerting
algorithm and the practicality of determining clusters in space and time.
4. Understand how poison center data can be fused with additional evidence sources.
5. Characterize the difference between existing approaches to assessments of health
quality and outcomes assessment, and more advanced forms of analytical
intelligence.
6. Identify the competencies, capabilities, and critical success factors associated with
using data and advanced analytics to derive more powerful insights in areas such as
population health management and bio surveillance.
7. Define roadmap and next steps organizations and individuals can undertake in
creating and deploying these new capabilities.
8:00 am – 9:00 am
Nottoway 4th floor
Informa Senior Editorial Board
8:15 am – 8:30 am
Borgne 3rd floor
PEC News & Events
Home
Next
Monday, October 20, 2014 , continued
8:00 am – 10:00 am
Maurepes 3rd floor
Conference Schedule
How to Teach Tox SIMS: High Fidelity Simulation Case
Debriefing - It's Not About the Dummy, Dummy!
Organizer: Tammi Schaeffer, DO
Presenter:
Jeffrey Holmes, MD
At the end of the session, the participant should be able to:
1. Explain the importance of a good debrief.
2. Describe the overall goal of an effective debrief.
3. List the components of a good debrief environment.
4. Describe the three phases of the CMS model of debriefing.
5. Describe the appropriate technique of advocacy and inquiry to elicit
participants' frames.
8:30 am – 9:00 am
Borgne 3rd floor
PEC: HRSA Updates
Presenter: RaMeicha Cooks, BS
At the end of the session, the participant should be able to:
1. Identify HRSA's current projects related to poison center promotion.
2. Recommend ways HRSA can support poison prevention programs.
9:00 am – 5:00 pm
Napoleon Foyer
toxiCall® Training
9:00 am – 9:30 am
Napoleon AB 3rd floor
Get Up Initiative
9:00 am – 11:00 am
Borgne 3rd floor
PEC: Drug Recognition Experts and the Drug
Impaired Driver
Presenter: Sgt. Robert B. Harris
At the end of the session, the participant should be able to:
1. Identify the most common substances of abuse that are causing drugged driving.
2. Understand the 12 step process used by Drug Recognition Experts to assess
impairment.
Previous
Monday, October 20, 2014, continued
Conference Schedule
3. Become familiar with the symptomatology that defines drug categorization.
9:30 am – 10:30 am
Napoleon AB 3rd floor
AACT Career Lectureship: When Statisticians Attack
Moderator: Milton Tenenbein
MD, FRCPC, FAAP, FAACT, FACMT
Presenter: William Banner
MD, PhD, FAAP, FCCM, FAACT, FACMT
At the end of the session, the participant should be able to:
1. Recognize the increasing incidence of descriptive manuscripts being
published in the medical literature.
2. Understand ways of undermining the strength of statistical analysis.
3. Understand the impact of statistical models on regression analysis.
4. Discuss the interaction of politics and science in creating public opinion and
legislation.
10:30 am – 12:00 pm
Napoleon AB 3rd floor
AACT Scientific Symposium: Increasing Naloxone
Availability as a Harm Reduction Measure for Opioid
Poisoning
Moderator: Susan Smolinske, PharmD
Steve Aks, DO, FACMT
Presenters: Daliah Heller
Mark Kinzly
Alexander Walley, MD, MSc
Daniel Wermeling, MD
Leo Beletsky, JD, MPH
At the end of the session, the participant should be able to:
1. Describe the potential of layperson administered naloxone for risk reduction.
2. Recognize the legal issues surrounding naloxone distribution.
Home
Next
Monday, October 20, 2014, continued
11:15 am – 12:15 pm
Borgne 3rd floor
Conference Schedule
Monday, October 20, 2014, continued
Conference Schedule
PEC: Key Messages and Core Functions of U.S.
Poison Centers: Survey Results
12:00 pm - 1:00 pm
817/821 8th floor
ACMT Position Statements and Guidelines
Committee
Presenters:
Alexa Steverson, MA
Wendy Stephan, MPH, CHES
12:00 pm - 1:00 pm
Bayside BC
4th floor
ACMT Education Committee
12:00 pm - 1:00 pm
815/820 8th floor
ACMT Military Section
12:00 pm – 1:00 pm
825/829 8th floor
ACMT Recent Graduate Section
1:00 pm - 2:30 pm
Waterbury Ballroom
2nd floor
AACT Fellows Abstract Platform Session
Moderators: Vik Bebarta, MD
Mark Kostic, MD
At the end of the session, the participant should be able to:
1. Develop a working knowledge of messages and services promoted to the public
consistently by all poison centers.
2. Evaluate areas in which your individual poison center may have unique abilities or
approaches to outreach compared to other centers.
3. Discuss how similarities and differences between poison centers may help or hurt
efforts to promote poison centers nationally.
4. Assess the role of the AAPCC in establishing core functions and key messaging
across poison centers.
12:00 pm - 1:00 pm
Lunch on Own
12:00 pm - 1:00 pm
Oak Alley 4th floor
AACT SIG and Committee Chairs Luncheon
Presenters:
The change in perceived risk associated with marijuana
use in the United States from 2002 to 2012
Jolene Okaneku, MD
12:00 pm - 1:00 pm
Bayside A 4th floor
ACMT Fellows - in - Training Luncheon: Initiating a
Forensic Toxicology Practice
Moderator: Christina Hantch-Bardsley, MD, FACMT
Extracorporeal life support (ECLS) for patients in shock or
cardiac arrest secondary to cardiotoxicant poisonings: a
cost-effectiveness analysis
Maude St-Onge, MD, MSc, FRCPC(EM), PhD (CAND)
Presenter:
Gerald Leikin, MD, FACMT, FAACT
Outcome of unintentional exposures to diethylene glycol
Katherine Welker, MD
At the end of the session, the participant should be able to:
1. Elaborate on the multitude of non-clinical revenue streams afforded to the Medical
Toxicologist.
2. Discuss logistics in initiating a revenue flow in Forensic-based Medical Toxicology.
12:00 pm - 1:00 pm
Nottoway 4th floor
Previous
AAPCC Committee Chair Fatality Team Luncheon
Immunoglobulin Concentration & Venom Binding Activity
of Expired Snake Antivenoms
Landen Rentmeester, MD
Lack of Association Between Drug Overdose Related
Deaths and Population Density
Chris Lim, MD
Home
Next
Monday, October 20, 2014, continued
Conference Schedule
At the end of the session, the participant should be able to:
1. State if the literature supports extracorporeal support for treatment of the poisoned
patient.
2. Describe the changes in public perception of marijuana use over the past 10 years.
3. Describe how the concentration of immunoglobulin in antivenom changes over time.
4. Predict the expected outcome of accidental diethylene glycol exposure.
5. State the relationship between population density and overdose in the U.S.
1:00 pm - 2:30 pm
Napoleon AB 3rd floor
CAPCC Symposium: Poison Centers and Public Health
Disaster Preparedness
Moderator: Martin Laliberté, MD, MSc, FRCPN
Presenters:
Toxicological Disaster Management - Antidote Stockpiling
Shaun Hosein, PhD
Chemical Antidote Stockpiling: The role of the poison
center and medical toxicologist in the management of
mass chemical exposures
Mark Kirk, MD
Chemical Antidotes Stockpiling: Response to Public
Health Emergencies
Susan Gorman, PharmD
At the end of the session, the participant should be able to:
1. Evaluate the current evidence supporting the use of chemical antidotes in mass
chemical exposures.
2. Describe the current situation and future directions for chemical antidote stockpiling
in Canada and in the United States.
3. Describe the design and the different components of the US Strategic National
Stockpile.
4. Describe the role of Poison Centres and Medical Toxicologists in the management
of mass chemical exposures.
Previous
Monday, October 20, 2014, continued
1:00 pm - 4:00 pm
Maurepas 3rd floor
Conference Schedule
SIM Teaching Lab: From Soup to Nuts - Design, Implement
and Debrief Your Own Toxicology Simulation Case
Organizer: Tammi Schaeffer, DO
Presenter:
Jeffrey Holmes, MD
At the end of the session, the participant should be able to:
1. Design, write and deliver a simulation scenario.
2. Demonstrate an effective debrief of a simulation scenario.
1:00 pm – 3:00 pm
817/821 8th floor
ToxSentry Data Group
1:30 pm –2:30 pm
Borgne 3rd floor
PEC: Unlocking the Silent Support of Poison
Centers in a Funding Crisis
Moderator: Alexa Steverson, MA
Presenters:
Carol DesLauriers, PharmD
Dennis O’Sullivan
Randy Skoglund, BA
At the end of the session, the participant should be able to:
1. Explain how various parts of the poison center mission create potential partners.
2. Identify which organizations are natural partners.
3. Utilize the Lewin Report to quantitate the financial value of poison centers in their
designated region.
4. Utilize social media to unlock public support for poison centers and
Influence decision makers.
2:30 pm – 3:30 pm
Napoleon Ballroom AB
3rd floor
Authors with Posters/ Abstracts 108-199 & 98-100
Home
Next
Monday, October 20, 2014, continued
3:30 pm - 4:00 pm
Borgne 3rd floor
Conference Schedule
PEC: Educational Research Award
Presenter: Liz Barta, RN, BSN, CHES
At the end of the session, the participant should be able to:
1. Explain the process of applying for and fulfilling the requirements of the PEC
Educators Research Award.
2. Describe the method utilized to provide poison center education to school nursed in
the identified project.
3. Define the evaluation method and results generated by the project discussed.
4. Appraise the applicability of this project's approach to similar populations in
participants' own service area.
5. Consider potential projects of their own that may be eligible for Educator Research
award funding.
3:30 pm - 4:30 pm
Napoleon AB 3rd floor
Platform Sessions II/Abstract 9-12
Moderators: Elizabeth Scharman, PharmD
Alex Campbell, MD
9. Prehospital ketamine for excited delirium in the setting of acute drug intoxication
J L Iwanicki1, W Barrett2, O Saghafi3, J Buchanan1, K J Heard1,
E J Lavonas1, K McVaney3 1Rocky Mountain Poison & Drug Center – Denver Health,
Denver CO USA; 2Colorado School of Medicine, Aurora CO USA; 3Denver Health
Medical Center, Denver CO USA
10. Diagnosis of snake envenomation using a simple phospholipase A2 assay
K P Maduwage1, M A O’Leary2, G K Isbister11School of Medicine and Public Health,
University of Newcastle, Callaghan, Australia; 2Department of Clinical Toxicology
and Pharmacology, Calvary Mater Newcastle, Waratah, Australia
11. A prospective, multicenter, double-blind, randomized, controlled, clinical trial
comparing Crotalinae Equine Immune F(ab’)2 and Crotalidae Polyvalent Immune Fab
(ovine) for the treatment of US Crotalinae envenomation S P Bush6, A-M Ruha1, S A
Seifert5, D L Morgan8, B J Lewis9, T C Arnold10, R F Clark13, W J Meggs6, E A
Toschlog6, S Borron14, J Haynes14, G R Figge11, D R Sollee12,
F M Shirazi7, R Wolk2, D Quan3, W Garcia-Ubbelohde4, L V Boyer7
Previous
Monday, October 20, 2014, continued
Conference Schedule
12. Reasons for hospital admission after Centruroides envenomation treated with
Antivenom E A Grossart2, D Stevens3, C Loveless-Faulkner3, F M Shirazi4, K
Boesen11Arizona Poison and Drug Information Center, Tucson AZ USA; 2Carl R.
Darnall Army Medical Center, Fort Hood TX USA; 3Banner Good Samaritan Poison
and Drug Information Center, Phoenix AZ USA; 4Center for Toxicology Pharmacology
Education and Research, Phoenix AZ USA
At the end of the session, the participant should be able to:
1. Describe the clinical experience of using Ketamine in the prehospital stage for
excited delirium.
2. Discuss the use of serum phospholipase A2 assay in the diagnosis of
Snakebite.
3. Describe the emergency department disposition of centuroides
envenomations.
4. To describe the clinical experience with the administration of a novel antivenom,
F(ab’)2, in United States Crotalinae emvenomations.
3:30 pm - 4:30 pm
Waterbury Ballroom
2nd floor
AACT Occupational Interactive Studies in Public Health
Symposium
Moderator/Presenter: David Vearrier, MD
At the end of the session, the participant should be able to:
1. Discuss Cased base education on cancer cluster investigation.
2. Discuss cased-based discussion of occupational exposure controls.
3. Discuss monitoring/surveillance following an inadvertent environmental release of
substance.
4:00 pm - 5:30 pm
Oak Alley 4th floor
ACMT Toxic Network
4:00 pm - 5:30 pm
Bayside A 4th floor
ACMT Med. Tox Fellows - in- Training Association (MTFITA)
4:00 pm - 5:30 pm
Nottoway 4th floor
PEC: Swap and Share
Moderator: Liz Barta, RN, BSN, CHES
Home
Next
Monday, October 20, 2014, continued
Monday,
October 20, 2014
Rooms
700am
730am
800am
8:15am
830am
900am
930am
1000am
1030am
Napoleon
Foyer 3rd Floor
11:15am
1130am
1200pm
12:15pm
1230pm
100pm
130pm
200pm
230pm
300pm
330pm
400pm
430pm
500pm
Poster Session II
Tear Down
Continental Breakfast 6:30 - 8:00/ Exhibits/Authors with Posters 2:30 to 3:30 / Posters# 108-199 & 98-100
AAPCC /CDC Joint Symposium:
Utilizing PCC Data for Public Health
Surveillance
Get Up
initiative
AACT Career
Lecturship
AACT Scientific Symposium :
Increasing Naloxone Availability as a
Harm Reduction Measure for Opioid
Poisoning
CAPCC Symposium: Poison
Centers and Public HealthDisaster Preparedness
Lunch
Waterbury
Ballroom 2nd
Floor
600pm
630pm
700pm
730pm
800pm
830pm
Break AWP
Platform II/Abstracts # 9-12
AACT Occupational Interactive
Studies in Public Health
Symposium
AACT Fellows Abstract
Platform Session
AACT SIG & Committee
Chairs lunch
ACMT ToxIC Network
Bayside A 4th
Floor
ACMT Fellows- inTraining Luncheon
ACMT Med Tox Fellows in
training Assoc. (MTFITA)
AAPCC Committee
Chair/Fatality Team
Luncheon
PEC: Swap & Share
Nottoway 4th
floor
Informa Senior Editorial Board
Borgne 3rd
Floor
PEC News
& Events
HRSA
Updates
PEC: Drug Recognition Experts and
the Drug Impared Driver
Break
PEC:Key Message and
Core Functions of US
Poison Center: Survey
Results
Bayside BC 4th
Floor
Lunch
PEC: Unlocking the
Silent Support of
Poison Centers in a
Funding Crisis
Break AWP
ACMT Education
Committee
ACMTPosition
Statements & Guidelines
Comm.
AAPCC Review Team
Meeting
825-829 8th
Floor
ACMT Recent Graduate
Section
816/820 8th
Floor
ACMT Military Section
Napoleon
Foyer 3rd Floor
900pm
Conference Schedule
930pm
At the end of the session, the participant should be able to:
1. Share information about innovative and creative programs.
2. Compare poison prevention material from a variety of poison centers.
Poster
Session III
Set Up: #200290
Oak Alley 4th
Floor
817/821 8th
Floor
530pm
NACCT Main Congress Registration/Information
Napoleon
Ballroom CD
3rd Floor
Napoleon AB
3rd Floor
1100am
4:30 pm - 6:00 pm
Bayside BC 4th floor
AAPCC Town Hall
6:00 pm – 9:00 pm
Offsite
Masquerade Ball & Dinner Cruise
(Transportation begins at 6pm until 6:45pm to Riverboat)
PEC:
Educational
Research Award
AAPCC Town Hall
Tuesday, October 21, 2014
Conference Schedule
ToxSentry Data Group
7:00 am - 5:00 pm
Napoleon Foyer
3rd floor
NAACT Main Congress Registration/Information
6:30 am – 8:00 am
Napoleon Ballroom CD
3rd floor
Continental Breakfast
7:00 am – 1:00 pm
Napoleon Ballroom CD
3rd floor
Exhibits/Abstracts #200-290
7:30 am - 8:30 am
Oak Alley 4th floor
AAPCC Managing Directors
7:30 am - 9:00 am
Napoleon AB
3rd floor
ACMT Scientific Symposium: Frontiers in Pain
Pharmacotherapy
Moderator: Louise Kao, MD, FACMT
toxiCall® Training
Offsite
Masquerade Ball & Dinner Cruise
Maurepas 3rd
Floor
How to Teach TOX SIMS
Color Key
Main
Symposia
AAPCC
ACMT
SIM Teaching Lab
AACT
ABAT
PEC
MISC
Private
Presenter: Theodore Cummins, MD
Beyond the Mu Receptor: Ion Channels and Their Role in
Pain Syndromes
Sodium Channel Toxins: Poisons That Hold Promise for
Developing Novel Therapies for Pain Management
Previous
Home
Next
Tuesday, October 21, 2014, continued
Conference Schedule
Tuesday, October 21, 2014, continued
Presenters:
New recreational drug abuse in Taiwan
Jou-Fang Deng, MD
At the end of the session, the participant should be able to:
1. Review the current knowledge regarding the roles of sodium, calcium and potassium
ion channels in pain signaling.
2. Discuss the recent insights that have been gained from studying inherited pain
syndromes.
3. Review the advantages and disadvantages of available drugs and describe new
compounds in clinical trials that target these channels.
4. Review the mechanisms of action insecticides, cancer chemotherapeutics and
biological toxins that induce pain and parenthesis.
5. Discuss the promise that biological toxins provide in the pursuit of developing
targeted sodium channel therapies for pain management.
8:00 am – 9:00 am
Borgne 3rd floor
PEC: Distance Learning Nuts and Bolts: How to Conduct a
Webinar
Presenter: Kristin Wenger, MAT
At the end of the session, the participant should be able to:
1. Perform the steps to set up and host a webinar.
2. Identify ways to use distance learning at your respective poison center.
Conference Schedule
Drug abuse and complications in Asia
Winai Wananukul, MD
Changing trend/pattern of drug abuse in different Asian
countries/regions: Indian Perspective
Ashish Bhalla, MD
Reza Afshari, MD
At the end of the session, the participant should be able to:
1. Describe the basic epidemiologic data of drug abuse and /or related poisoning in
different parts of Asia.
2. Report the changing trend of drug abuse especially that related to novel
psychoactive substances (NPS) in different parts of Asia.
3. Discuss the difficulties in the diagnosis and management of NPS in different parts of
Asia.
4. Describe how international collaboration can be conducted to collect better
information on and to encounter the public health threat attributable to NPS and
other abused substances.
8:30 am – 9:30 am
Oak Alley 4th floor
Toxicall Users Group
8:30 am – 11:30 pm
Bayside C 4th floor
Flu On Call Y2 Update for Pilot Site Participants
(Flu on Call Pilot sites ONLY)
9:00 am – 10:00 am
Nottoway 4th floor
PEC: NACCT 2015 Conference Planning
9:00 am – 5:00 pm
Napoleon Foyer
toxiCall® Training
9:00 am – 10:00 am
Bayside A 4th floor
AACT Acute and Intensive Care SIG
9:00 am – 10:00 am
Napoleon Ballroom AB
3rd floor
APAMT Symposium: Drug Abuse and Complications in
Asia
Moderator: Chen-Chang Yang, MD, MPH, DrPH
10:00 am – 11:00 am
Napoleon Ballroom AB
3rd floor
Authors with Posters/Abstracts #200-290
Previous
Home
Next
Tuesday, October 21, 2014, continued
11:00 am – 12:00 pm
Napoleon B 3rd floor
Conference Schedule
AACT Articles You May Have Missed
Moderator: Greene Shepherd, PharmD
Presenters:
Anna Dulaney, PharmD
Kapil Sharman, MD
Greene Shepherd, PharmD
At the end of the session, the participant should be able to:
1. Describe three recent articles relevant to clinical toxicology.
2. Identify key strengths and weaknesses of these articles.
3. Describe these articles implications for current and future practice.
11:00 am – 12:00 pm
Napoleon A 3rd floor
AAPCC Veterinary Symposium: Marijuana
Exposures in Animals
Moderator: Tina Wismer, DVM, DABVT, DABT
Panel Session:
Tina Wismer, DVM, DABVT, DABT
Jon Cole, MD
Jan Scaglione, PharmD, DABAT
Ahna Brutlag
Donna Menshing, DVM, MS, DABVT, DABT
Paul Starr, PharmD, DABAT
At the end of the session, the participant should be able to:
1. Identify differences between veterinary and human toxicology approaches to
pediatric and canine exposures to marijuana
2. Evaluate testing methods for determining positive exposure to marijuana in canine
and pediatric populations and implications for clinical use
3. Discuss confounders associated with legalizing marijuana and implications for
human and veterinary toxicology
11:00 am – 12:00 pm
Oak Alley 4th floor
Previous
Tuesday, October 21, 2014, continued
11:00 am – 12:00 pm
Borgne 3rd floor
Conference Schedule
PEC: MADD Using Proven Education Methods to Reduce
Underage Alcohol Use
Moderator: Wendy Stephan, MPH, CHES
Presenter: Sunny Wall
At the end of the session, the participant should be able to:
1. Describe the acute impact of alcohol abuse on deaths and hospitalizations in the
U.S.
2. Recognize the leading role of MADD in alcohol abuse and underage drinking
prevention efforts nationally.
3. Discuss recent evidence-based programs used by MADD to teach parents about
promoting safe alcohol use in their children and college-age youth.
4. Identify ways in which the demonstrated alcohol safety messages or methods may
be incorporated into poison prevention educators' practices.
5. Locate contact information for MADD chapters serving area(s) for training or
referrals.
11:00 am – 2:00 pm
Offsite
ABAT Business Meeting/Reception at New Orleans
Pharmacy Museum
12:00 pm – 1:00 pm
Napoleon B 3rd floor
LUNCH
12:00 pm – 1:00 pm
Napoleon A 3rd
Toxicology History Symposium
Moderator: Bryan Judge, MD
Presenters:
The Buzz About Bees
Anthony Tomassoni, MD
Weapons of Mass Destruction considered during the U.S.
Civil War
Mark Laubacher, RN, EMT-P
AACT Radiation WMD SIG
Home
Next
Tuesday, October 21, 2014, continued
Conference Schedule
At the end of the session, the participant should be able to:
1. List three chemicals considered to be used as a weapon by Union or
Confederate forces during the US Civil War.
2. Name the disease involving a plot to infect citizens of major Northern cities and
President Lincoln.
3. State two explanations for the lack of use of mass destruction weapons during the
US Civil War.
4. Understand basics for the bee venom delivery apparatus and know the differences
between bee (Apidae) and wasp (Vespidae) venoms.
5. Become familiar with the natural course and potential complications of bee
envenomation and their Treatment.
6. Become aware of the possibility of toxic etiologies contributing to the
seemingly multifactorial "colony collapse syndrome" and potential impacts on food
production and the economy due to the loss of honey bee colonies.
12:00 pm – 1:00 pm AACT Fellows- in –Training Luncheon
Nottoway A 4th floor
12:00 pm – 1:00 pm
Bayside A 4th floor
AHLS Executive Committee
12:00 pm – 1:00 pm
Oak Alley 4th floor
AAPCC Government Affairs
12:00 pm – 1:00 pm
Bayside B 4th floor
CAPCC Business Meeting
12:00 pm – 1:00 pm
Bayside C 4th floor
ACMT ATSDR Network Meeting
12:00 pm – 1:00 pm
Maurepas 3rd floor
ACMT Research Committee
Previous
Tuesday, October 21, 2014, continued
1:00 pm – 2:00 pm
Napoleon Ballroom A
3rd floor
Conference Schedule
AACT SIG Radiation Safety/WMD Symposium: Assessment
of Internal Contamination: What every Toxicologist Should
Know
Moderator: Adam Pomerleau, MD
Update on Internal Contamination with Radionuclides
Presenter: Ronald Goans, PhD, MD, MPH
At the end of the session, the participant should be able to:
1. Describe factors that affect the management of internal contamination.
2. Discuss available laboratory testing capabilities in emergency and non-emergency
situations.
3. Discuss the significance and proper use of a Clinical Decision Guide.
4. List 3 existing medical countermeasures for the treatment of internal contamination
with radionuclides.
1:00 pm – 2:30 pm
Napoleon B 3rd floor
Public Educators Symposium: Promoting Food Safety;
Surveillance, Partnerships and Education
Moderator: Alexa Stevenson, MA
Presenters:
Erin DeLaune, MPH
LuAnn White, PhD, DABT
Wendy Stephan, MPH, CHES
At the end of the session, the participant should be able to:
1. Interpret the national data on foodborne illness in light of what is typically seen by
poison centers
2. Evaluate the risk to the public from various food contamination sources
3. Apply knowledge of current food safety guidelines and resources to actively promote
the use of poison control centers for food poisoning-related concerns
4. Develop a plan for inclusion of food safety education into existing poison prevention
programming
Home
Next
Tuesday, October 21, 2014, continued
2:00 pm – 3:00 pm
Napoleon A 3rd floor
Conference Schedule
AAPCC SPI Clinical Symposium: Emerging Drugs of
Abuse: Finding the Reality Beneath the Headline
Moderator: Jamie Cook, RN, MSN, CSPI
Maggie Purcell, RN, MS, CSPI
Presenter:
Drugs of Abuse Public Health Threat - The Chasm Between
Hype and Reality
Tamas, Peredy MD, FACEP, FACMT
At the end of the session, the participant should be able to:
1.
2.
3.
4.
Differentiate between the new and emerging drugs of abuse and their effects.
Discuss the effect of mass media on the reputation of emerging drugs of abuse.
Describe how the reputation of drugs of abuse aligns with pop culture and fantasy.
Identify the mechanism of stimulation and movement disorders associated with the
use of specific hallucinogenic stimulants.
5. Provide accurate information regarding the new drugs of abuse to the general public.
2:30 pm – 3:30 pm
Napoleon B 3rd floor
AACT Acute & Intensive Care Symposium
Moderators: Jenny Lu, PharmD
Bryan Hayes, PharmD
Presenters:
Severe Refractory Cardiotoxicity following Inhalation of
1,1-difluoroethane
Robert Bassett, DO
Lead Toxicity
Jakub Furmaga, MD
At the end of the session, the participant should be able to:
1. Discuss controversies related to treatment of dysrhythmias from inhalant abuse.
2. Discuss difficult management issues related to pediatric lead poisoning.
Previous
Tuesday, October 21, 2014, continued
2:30 pm – 3:30 pm
Borgne 3rd floor
Conference Schedule
PEC: The Art of Presentation: How to Address Education
Barriers and Audience Segmentation (Part 2) (you must
have attended Part 1 in order to attend this session)
Moderator: Alexa Steverson, MA
Presenter: Jennifer Watson, BS
Charise Thomason, MPH
Mike Yudizky, BS
At the end of the session, the participant should be able to:
1. Synthesize research findings rapidly and create interesting and engaging
educational programs for targeted audience segments.
2. Recognize and overcome common challenges in developing new materials and
programs.
3:00 pm – 4:00 pm
Napoleon A 3rd floor
AAPCC SPI Best Practices Symposium: Button Battery
Ingestion
Moderator: Brooke Button, RN, BScN, CSPI
Sherri Ellis, RN, BS, CSPI
Presenters:
Fredrick Henretig, MD
Toby Litovitz, MD
At the end of the session, the participant should be able to:
1. Describe the risks of button battery ingestions in young children including the scope
of severe injuries that may result.
2. Explain the mechanism of injury, the lack of systemic toxicity, and the urgency of
battery removal.
3. Recognize differentiating physcial features of a button battery on x-ray, including the
direction of the negative pole and its predictive value.
4. Describe the frequency and severity trends over time for battery ingestions reported
to poison centers.
5. Recommend battery ingestion prevention modalities that are informed by data.
6. Triage battery ingestion cases appropriately based on age of the patient and size of
the ingested battery.
Home
Next
Tuesday, October 21, 2014, continued
3:30 pm – 4:30 pm
Napoleon B 3rd floor
Conference Schedule
Platform III Abstracts #13-16
Moderators: Maria Mercurio-Zappala, RPh MS, FAACT
Irma DeVries, MD, FAACT
13. The effect of ginkgo biloba and panax ginseng on driving ability: A pilot study
R G Mckeever, G S Lasala, D Vearrier, M I Greenberg Drexel University College of
Medicine, Philadelphia PA USA
14. Impact of ethanol on integrity of the sustained release properties of Avinzaâ
M Hodgman3, M G Holland3, U Englich2, S M Wojcik1, W D Grant1
15. Epidemiology of patients in whom levamisole was detected in comprehensive
urine drug screens J H Yanta1, A F Pizon1, K Tamama2, N B Menke11Division of
Medical Toxicology, Department of Emergency Medicine, University of
Pittsburgh Medical Center, Pittsburgh PA USA; 2Division of Clinical Chemistry,
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh PA
USA
16. A novel bedside analysis for formate in methanol poisonings – A pilot study
K E Hovda1, G Gadeholt2, V Evtodienko4, D Jacobsen3 1Department of Acute
Medicine, The Norwegian CBRNe Centre of Medicine, Oslo
University Hospital, Oslo Norway; 2Department of Pharmacology, Clinical Pharmacology,
Oslo University Hospital, Oslo Norway; 3Department of Acute Medicine, Oslo University
Hospital, Oslo Norway; 4Evik Diagnostics, Ottawa ON Canada
At the end of the session, the participant should be able to:
1. Describe the possible effect of Ginkgo Biloba and Panax Ginseng on driving ability.
2. Discuss the effect of ethanol on the intergrity of sustained release preparation of
Avinza.
3. Describe the epidemiology of Levamisole detection in urinary drug screens.
4. Discuss the use of a novel bedside assay for format acid in methanol poisoning.
4:00 pm – 5:00 pm
Napoleon Ballroom CD
3rd floor
Previous
Tuesday, October 21, 2014, continued
4:00 pm – 5:00 pm
Napleon Ballroom A
Conference Schedule
AAPCC SPI Roundtable Symposium: Colchicine:
Treatment Fit for a King
Moderator: Kristie Williams, PharmD, SPI
Lori Salinger, RNc, MSN, CSPI
Presenters:
Managing a Colchicine Overdose and What Makes it
Unique
Randy Badillo, RN, BSN, CSPI
Joanne Masur, RN
Expert Panel:
Sophie Gosselin, MD
Anthoney Pizon, MD
Stephanie Lynn Hon, PharmD
Greene Shepherd, PharmD
At the end of the session, the participant should be able to:
1. Review the unique presentation and progression of symptoms related to the
symptomatic colchicine patient.
2. Increase SPI's awareness of the low range of toxicity that may produce significant
morbidity and mortality.
3. Understand the mechanism of action of colchicine and how it may be similar to a
radiation exposure.
4. Review the symptoms in VPA overdose, both common and rare.
5. Describe the role of decontamination as it relates to VPA toxicity.
6. Discuss the role of enhanced elimination in VPA toxicity.
7. Consider when to begin enhanced elimination in symptomatic VPA overdose.
Poster Session III Tear Down
Home
Next
Tuesday, October 21, 2014, continued
Conference Schedule
Tuesday,
October 21, 2014
Rooms
4:30 pm – 5:30 pm
Napoleon B 3rd floor
Toxicology News Hour: Focus on Marijuana Legalization
and Zohydro
Moderator: Diane Calello, MD, FAAP
Presenters:
Alexander Garrard, PharmD, DABAT
Janetta Iwanicki, MD
Lewis Nelson, MD, FACMT, FAACT
A.Kaye, MD
David Juurlink, MD, PhD, FAACT, FACMT, FRCPC
700am
730am
1.
2.
3.
4.
Understand the epidemiology of marijuana legalization.
Understand the local impact of marijuana legalization.
Better understand the process of FDA approval.
Understand the unique FDA evaluation of Zohydro.
Previous
NACCT Partnership Meeting
830am
900am
9:30am
9:45am
Napoleon Ballroom
CD 3rd floor
Napoleon Ballroom
AB 3rd Floor
1000am
1030am
1100am
1130am
1200pm
1230pm
Continental Breakfast 6:30-8:00am/ Exhibits / Authors with Posters 10:00 to 11:00 Abstracts# 200-290
ACMT Scientific Symposium:
Frontiers in Pain
Pharmacotherapy
APAMT
Symposium:Drug
Abuse and
Complications in Asia
Napoleon B 3rd Floor
Napoleon A 3rd Floor
1:15pm
130pm
200pm
2:15pm
230pm
300pm
330pm
400pm
430pm
500pm
530pm
600pm
630pm
700pm
730pm
800pm
830pm
900pm
930pm
Break (AWP)
Articles You May
Have Missed
Lunch
Break (AWP)
AAPCC
Veterinary
Symposium:
Marijuana
Exposures in
A i l
Toxicology
History
Symposium
PEC Conference
Planning
AACT Fellows in
Training Lunch
Bayside A 4th Floor
AACT Acute and
Intensive Care SIG
AHLS Executive
Committee
AAPCC Managing
Directors
Toxicall Users
Group
AACT Radiation/
WMD SIG
C
sta ce
Learning Nuts
and Bolts:
How to
Conduct a
W bi
Break AWP
Us g
Proven
Education
Methods to
Reduce
U d
Bayside B 4th floor
Flu On Call™ Y2 Update for Pilot Site Participants (Flu
On Call™ Pilot sites only)
Bayside C 4th Floor
Poster
Session III
Tear Down
Break (AWP)
Nottoway 4th Floor
Oak Alley 4th Floor
100pm
NACCT Main Congress Registration/Information
Napoleon Foyer 3rd
Floor
AACT Acute &
Platform III/
Public Educators Symposium:
Toxicology
Promoting Food Safety: Surveillance, Intensive Care Abstracts #13News Hour
Partnerships, and Education
Symposium
16
Safety/WMD
AAPCC SPI Clinical
AAPCC SPI
AAPCC SPI
Symposium:
Symposium:
Roundtable
Best Practices
Assessment of
Emerging Drugs of
Symposium:C
Symposium:
Internal
Abuse: Finding the
olchicine:
Button Battery
contamination: What Reality Beneath the
Treatment fit
Ingestion
E
T i l i t
H dli
f
Ki
NACCT
Partnership
AAPCC
Government
Affairs
Lunch
PEC: The Art of
Presentation
Part 2
CAPCC
Business
Meeting
ACMT ATSDR
Network Meeting
toxiCall® Training
ACMT Research
Committee
Maurepas 3rd floor
ABAT Business Meeting
@New Orleans Pharmacy
Museum
Offsite
Color
Key
5:30 pm – 6:30 pm
Nottoway 4th floor
800am
Napoleon Foyer 3rd
Floor
Borgne 3rd Floor
At the end of the session, the participant should be able to:
7:45am
Main
Sympo AAPCC ACMT AACT ABAT
sia
PEC
ABAT Fellows Reception @
New Orleans Pharmacy
Museum
MISC Private
Home
Next
Wednesday,
October 22, 2014
Rooms
POST CONFERENCE
700am
730am
7:45am
800am
830am
900am
9:30am
9:45am
1000am
1030am
1100am
1130am
Borgne 3rd Floor
1200pm
1230pm
100pm
1:15pm
130pm
200pm
230pm
300pm
330pm
400pm
430pm
500pm
530pm
600pm
630pm
700pm
730pm
800pm
830pm
900pm
930pm
AHLS Training
Maurepas 3rd
Floor
AAPCC Board Meeting II
Color
Key
Main
Sympo AAPCC ACMT AACT ABAT
sia
PEC
MISC Private
Thursday
October 23, 2014
Rooms
POST CONFERENCE
700am
730am
7:45am
800am
830am
900am
9:30am
9:45am
1000am
1030am
1100am
1130am
Borgne 3rd Floor
1200pm
1230pm
100pm
1:15pm
130pm
200pm
230pm
300pm
330pm
400pm
430pm
500pm
530pm
600pm
630pm
700pm
730pm
800pm
830pm
900pm
930pm
AHLS Training
Color
Key
Main
Symposi AAPCC ACMT AACT ABAT
a
PEC
MISC
Friday
October 24, 2014
POST CONFERENCE
Room Name
700am
730am
7:45am
800am
830am
900am
Borgne 3rd Floor
9:45am
1000am
1030am
1100am
1130am
1200pm
1230pm
100pm
1:15pm
130pm
200pm
230pm
300pm
330pm
400pm
430pm
500pm
AHLS Training
Main
Sympo AAPCC
sia
Previous
9:30am
Continued
Education
ACMT
AACT ABAT
PEC
MISC
Home
Next
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
CONTINUING EDUCATION CREDIT
Continuing education credits for pharmacists and physicians are awarded by the American
Academy of Clinical Toxicology. Application for nursing credits has been submitted to the
California Board of Nursing.
Requirements for Successful Completion
To successfully complete the requirements for Continuing Medical Education (CME) credit,
Continuing Pharmaceutical Education (CPE) credit, or Continuing Education Contact Hours
(Nursing), completes the following steps:
1. Submit the required Continuing Education Credit fee ($175 for the main Congress, $70 for each
Pre-meeting Symposium).
2. Complete an online evaluation form for each session attended. Go to
www.prolibraries.com/nacct/redeem and enter your Conference Code NACCT14, verify your
attendance and create an account. If you previously set up an account, enter your username
and password. Click on “Sessions Evaluations” and select the session(s) you need to evaluate.
Also complete the total “Conference Evaluation”.
3. Your CE Certificate can be accessed and printed anytime after you have completed the
evaluation process by clicking on “CE Transcript” under “Your Account”.
4. IMPORTANT: In order to obtain contact hours for the sessions you attended, you MUST
complete the online evaluation process by November 29, 2014.
Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and
Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship
of the American Academy of Clinical Toxicology, American Association of Poison Control Centers,
American College of Medical Toxicology, Canadian Association of Poison Control Centres, and
European Association of Poison Centres and Clinical Toxicologists. The American Academy of
Clinical Toxicology is accredited by the ACCME to provide continuing medical education for
physicians.
American Academy of Clinical Toxicology, Inc. is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education.
Continuing Education Credit
This program was designed in accordance with the Accreditation Council for Pharmacy Education’s
Accreditation Standards and the Essential Areas and Policies of the Accreditation Council for
Continuing Medical Education.
The American Academy of Clinical Toxicology designates this educational activity for a maximum of
43.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the
extent of their participation in the activity.
This Congress will have multiple ACPE Universal Program Numbers. Pharmacists can earn up to a
maximum of 42.5 continuing education credit hours. Each pharmacist should claim only those
hours of credit that he/she actually spent in the educational activity.
NAACT will be utilizing CPE Monitor for tracking and reporting of all ACPE-accredited continuing
pharmacy education activities. Pharmacists are required to complete their e-profile
at www.nabp.net in order to obtain their NABP e-Profile ID. Please remember that you will need to
submit the NABP e-profile ID and birth date to receive credit at this year's meeting.
Application for nursing credits has been submitted to the California Board of Nursing. Nurses can
earn up to a maximum of 46 continuing education credit hours. Contact hours will not be awarded
for more than one concurrent session.
The American Academy of Clinical Toxicology is a designated provider of continuing education
contact hours (CECH) in health education by the National Commission for Health Education
Credentialing, Inc. The AAPCC Public Education Track is designated for Certified Health Education
Specialists (CHES) to receive up to 16.5 total Category 1 continuing education contact hours.
Maximum advanced-level continuing education contact hours available are 14.5. NCHEC Provider
# SEP4539
(NOTE: Shaded areas denote concurrent sessions. Full credit will not be awarded for both sessions within a
concurrent time block. Although poster sessions will be a part of the North American Congress of Clinical Toxicology
2014, except under special circumstances they will not be eligible for continuing education credit.)
Previous
Home
Next
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
Continuing Education Sessions
Session
ACPE Program Number
MD
RN
RPH
October 17, 2014
ACMT Pre Meeting Symposium: At the precipice of
0225-9999-14-200-L05-P
quality health care: The role of the toxicologist in
(K)
enhancing patient and medication safety
October 18, 2014
7.25
AACT Pre Meeting Symposium: Critical Care Update for
the Toxicologist
ACMT Clinical Pathophysiology (CPC)
0225-9999-14-201-L05-P
(K)
0225-9999-14-204-L04-P
(K)
October 19, 2014
7.75
9.3
2.0
2.4
0225-9999-14-205-L04-P
(K)
0225-9999-14-222-L04-P
(K)
0225-9999-14-206-L04-P
(K)
0225-9999-14-207-L04-P
(K)
0225-9999-14-208-L04-P
(K)
1.0
1.2
1.0
1.0
1.2
1.0
2.0
2.4
2.0
0.5
.06
0.5
2.0
2.4
2.0
0225-9999-14-209-L05-P
(K)
0225-9999-14-210-L05-P
(K)
0225-9999-14-211-L05-P
(K)
0225-9999-14-212-L04-P
(K)
0225-9999-14-213-L04-P
(K)
0225-9999-14-214-L05-P
(K)
0225-9999-14-215-L05-P
(K)
0225-9999-14-216-L04-P
(K)
0225-9999-14-217-L04-P
(K)
1.0
1.2
1.0
1.0
1.5
1.0
2.0
2.4
2.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
Keynote Presentation
ACMT Ellenhorn Lecture: Whole Bowel Irrigation:
Conception, Development, Acceptance and Application
How to Teach Tox SIM
AAPCC Updates
EAPCCT Symposium: New recreational drugs of abuse Developments in Europe and North America. How can
we improve collaborations to detect these sooner?
PEC: A Harm Reduction Approach to Injury Prevention:
Naloxone Rescue Kits in the Community
PEC Poison Myth vs. Fact: Internet, Folklore, and Other
Remedies
Platform Session I
PEC: When the Water Isn't Safe to Drink: Inside the
West Virginia Water Crisis
PEC:The Art of Presentation: How to Address Education
Barriers and Audience Segmentation
ACMT Practice Symposium: The Creation and
Preservation of a Medical Toxicology Service
ABAT Symposium: Clinically relevant herb-drug
interactions: Past, present, future
PEC: Poisons in Pop Culture VI: 2014 NACCT Team
Trivia
ACMT Fellows-in-Training Roundtable Symposium:
Evaluation of Job Options
8.7
1.0
7.25
7.75
2.0
1.0
October 20, 2014
AAPCC/CDC Joint Symposium: Utilizing PPC Data for
Public Health Surveillance
Previous
0225-9999-14-218-L04-P
(K)
2.0
2.4
2.0
How to Teach Tox SIM
0225-9999-14-219-L04-P
(K)
2.0
2.4
2.0
HRSA Updates
0225-9999-14-220-L04-P
(K)
0225-9999-14-221-L04-P
(K)
0225-9999-14-248-L04-P
(K)
0225-9999-14-223-L03-P
(K)
0.5
0.6
0.5
2.0
2.4
2.0
1.0
1.2
1.0
1.5
1.8
1.5
0225-9999-14-224-L04-P
(K)
1.0
1.2
1.0
0225-9999-14-225-L04-P
(K)
0225-9999-14-226-L04-P
(A)
AACT Fellow's Abstract Platform Session
0225-9999-14-227-L04-P
(K)
PEC: Unlocking the Silent Support of Poison Centers in a 0225-9999-14-228-L04-P
Funding Crisis
(K)
Platform Session II
0225-9999-14-229-L04-P
(K)
AACT Occupational Interactive Studies in Public Health
0225-9999-14-230-L04-P
Symposium
(K)
PEC: Educator Research Award: Outreach to School
0225-9999-14-231-L04-P
Nurses
(K)
PEC: Swap & Share
0225-9999-14-232-L04-P
(K)
October 21, 2014
1.5
1.8
1.5
3.0
3.6
3.0
1.5
1.8
1.5
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
0.5
.6
0.5
1.5
1.8
1.5
1.5
1.8
1.5
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.5
1.8
1.5
1.0
1.2
1.0
PEC Drug Recognition Experts and the Drug-Impaired
Driver
AACT Career Lectureship
AACT Scientific Symposium: Increasing Naloxone
availability as a harm reduction measure for opioid
poisoning
PEC: Key Messages and Core Functions of U.S. Poison
Centers:Survey Results
ACMT Fellows-in-Training Luncheon
CAPCC Symposium: Poison Centers and Public HealthDisaster Preparedness
SIM Teaching Lab
ACMT Scientific Symposium: Frontiers in Pain
Pharmacotherapy
PEC: Distance Learning Nuts and Bolts: How to Conduct
a Webinar
APAMT Symposium: Drug Abuse and Complications in
Asia
AACT Articles You May Have Missed
AAPCCC Veterinary Symposium: Marijuana Exposures in
Animals
PEC: MADD Using Proven Education Methods to Reduce
Underage Alcohol Use
Toxicological Historical Society
Public Educators Symposium: Promoting Food Safety:
Surveillance, Partnerships, and Education
AACT SIG Radiation Safety/WMD Symposium:
Assessment of Internal contamination: What every
toxicologist should know
0225-9999-14-233-L01-P
(K)
0225-9999-14-234-L04-P
(K)
0225-9999-14-235-L04-P
(K)
0225-9999-14-236-L04-P
(K)
0225-9999-14-237-L04-P
(K)
0225-9999-14-238-L04-P
(K)
0225-9999-14-239-L04-P
(K)
0225-9999-14-240-L04-P
(K)
0225-9999-14-241-L04-P
(K)
1.0
Home
Next
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
SPI Clinical Symposium: Emerging Drugs of Abuse:
Finding the Reality Beneath the Headline
AACT Acute and Intensive Care Symposium
PEC: The Art of Presentation: How to Address Education
Barriers and Audience Segmentation
SPI Best Practices Symposium: NACCT 2014 Button
Battery Ingestion
Platform Session III
SPI Roundtable: Colchicine: Treatment Fit for a King
Toxicology News hour
0225-9999-14-242-L04-P
(K)
0225-9999-14-243-L04-P
(K)
0225-9999-14-244-L04-P
(K)
0225-9999-14-245-L04-P
(K)
0225-9999-14-246-L04-P
(K)
0225-9999-14-247-L04-P
(K)
0225-9999-14-249-L03-P
(K)
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
1.0
1.2
1.0
Maximum Hours
43.5
50.4
42.5
“K” denotes knowledge-based activity; “A” denotes application-based activity
DISCLOSURE OF SIGNIFICANT RELATIONSHIPS WITH
RELEVANT COMMERCIAL COMPANIES/ORGANIZATIONS
The ACCME Standards for Commercial Support and ACPE Non-Commercialism Standards require
presentations be free of commercial bias and that any information regarding commercial products /
services be based on scientific methods generally accepted by the medical community. According
to the American Academy of Clinical Toxicology “Policy on Non-Commercialism and Fair Balance”,
all faculty, authors, editors, and planning committee members (including their immediate family
members) participating in an AACT-sponsored activity are required to disclose any relevant
financial interest or other relationship (1) with the manufacturer(s) of any commercial
products(s) and /or provider(s) of commercial services discussed in an educational presentation
and (2) with any commercial supporters of the activity. Should potential conflicts of interest be
identified, AACT will resolve all conflicts of interest prior to the education activity being delivered to
learners. Presentations offered by a person with a potential conflict of interest are required to
submit a detailed outline of the presentation, which will be used by ACCT to confirm the scientific
objectivity of the presentation. The audience will also be afforded the opportunity to evaluate
whether the speaker’s interests or relationships influenced the presentation with regard to
exposition or conclusion through the use of the program evaluation instrument. Faculty, authors,
editors or planning committee members that do not provide disclosure are ineligible to participate in
the continuing education activity.
Previous
Relevant financial interest is defined as a financial relationship with a commercial interest in
any amount occurring within the last 12 months that creates a conflict of interest. Financial
relationships are those relationships in which the individual benefits by receiving a salary, royalty,
intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options
or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial
benefits are usually associated with roles such as employment, management position, independent
contractor (including contracted research), consulting, speaking and teaching, membership on
advisory committees or review panels, board membership, involvement in litigation and other
activities from which remuneration is received, or expected. AACT considers relationships of the
person involved in the continuing education activity to include financial relationships of a spouse or
partner. A “commercial interest” is any proprietary entity producing health care goods or services,
with the exemption of non-profit or government organizations and non-health care related
companies. Circumstances create a conflict of interest when an individual has an opportunity to
affect continuing education content about products or services of a commercial interest with which
he/she has a financial relationship.
This educational activity has been planned to be well-balanced and objective in discussion of
available treatment regimens. Interpretations and opinions offered by the authors represent their
viewpoints. Conclusions drawn by the participant should be derived from careful consideration of
all available scientific information.
When therapeutic options are discussed, it is our preference that only generic names be used. If it
is necessary to use a trade name, then those of several companies must be used, if available.
Products may be discussed in the treatment of indications outside current approved labeling.
Speakers are required to disclose this to the participants.
Home
Next
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
Speaker Disclosure of Commercial Affiliations
Relevant Financial Relationship to Commercial Interests
October 17
Silas Smith
Robin Hemphill
Luke Yip
Allen Vaida
Keith Burkhart
Alfred Aleguis, Jr
Brenna Farmer
Erica Lieblet
Jeanmarie Peronne
ACMT Pre-Meeting Symposium
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
October 18, 2014
AACT Pre-Meeting Symposium
Samantha Wood
Nothing to Disclose
Kristin Engebrestsen
Nothing to Disclose
Norman Paradis
Zoll Inc., BG Medicine Inc.,Venaxis Inc. Consultant
Scott Phillips
Nothing to Disclose
Christian Tomaszewski
Nothing to Disclose
Darren Roberts
Nothing to Disclose
Matt Zuckerman
Nothing to Disclose
Mark Mycyk
Stock/ Medical Director; TASER
Katherine Jennings
Nothing to Disclose
Peter Deblieu
Pending
Jean Abbott
Nothing to Disclose
Constantine Dimitriades
Nothing to Disclose
Tammi Schaeffer
Nothing to Disclose
Robert Palmer
Nothing to Disclose
ACMT CPC Competition
All CPC participants have completed conflict of interest
Nothing to Disclose
disclosure forms, which are on file with the AACT Education
Committee.
October 19, 2014
Keynote Presentation
Deborah Blum
Nothing to Disclose
ACMT Ellenhorn Award
Milton Tennenbein
Nothing to Disclose
How To Teach Sims
CAE Healthcare METI Division is supplying the use of a high-fidelity simulator for the 3 days of the course. Neither organizers nor AACT are
receiving any direct financial support from CAE Healthcare other than provision of the simulator and supplies used on the simulator. Unless
otherwise noted, faculty teaching the simulation sessions has no financial disclosures with CAE Healthcare nor are they receiving any
financial compensation.
Jeffrey Holmes
Richard W Low II BA
Previous
Nothing to Disclose
Employee, CAE
Krista Osterthaler
Bruno Megarband
David Wood
Relevant Financial Relationship to Commercial Interests
AAPCC Updates
Nothing to Disclose
EAPCCT Symposium
Nothing to Disclose
Guy’s an St. Thomas NHS Foundation Trust, Paid Speaker
Irma De Vries
Nothing to Disclose
PEC: A Harm Reduction Approach to Injury Prevention
Tessie Castillo
Nothing to Disclose
PEC Poison Myth vs. Fact: Internet, Folklore, and Other Remedies
Jill Michels
Nothing to Disclose
Platform Session I
David Juurlink
Nothing to Disclosure
Taylor Conrad
Nothing to Disclosure
Victoria Anderson
Nothing to Disclose
Amy Elizabeth Zosel
Nothing to Disclose
Gillian Beauchamp
Nothing to Disclose
Elizabeth Scharman
Nothing to Disclose
Anthony Pizon
Nothing to Disclose
Shan Yin
Nothing to Disclose
PEC:The Art of Presentation: How to Address Education Barriers and Audience Segmentation
Jennifer Watson
Nothing to Disclose
Charise Thomason
Nothing to Disclose
Mike Yudizky
Nothing to Disclose
ACMT Practice Symposium
Daniel Brooks
Banner Health System, Full time Employee
Bryan Judge
Nothing to Disclose
Ayrn O’Connor
Nothing to Disclose
ABAT Symposium
Billy J.Gurley Jr.
Nothing to Disclose
PEC: Poisons in Pop Culture VI: 2014 NACCT Team Trivia
JoAnn Chambers-Emerson
Nothing Disclose
Joseph J Rasimas
Paul Wax
Jeffrey Brent
ACMT Fellows-in-Training Roundtable Symposium
Nothing Disclose
Nothing to Disclose
Nothing to Disclose
October 20, 2014
AAPCC/CDC Joint Symposium
Royal Law
Nothing to Disclose
Howard Burkom
Nothing to Disclose
Jason Burke
UNC Health Care System, Full-time employee
How to Teach Tox SIM
CAE Healthcare METI Division is supplying the use of a high-fidelity simulator for the 3 days of the course. Neither organizers nor AACT are
receiving any direct financial support from CAE Healthcare other than provision of the simulator and supplies used on the simulator. Unless
otherwise noted, faculties teaching the simulation sessions have no financial disclosures with CAE Healthcare nor are they receiving any
financial compensation.
Jeffrey Holmes
Nothing to Disclose
Home
Next
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
Relevant Financial Relationship to Commercial Interests
Employee, CAE
HRSA Updates
RaMeicha Cooks
Nothing to Disclose
PEC Drug Recognition Experts and the Drug-Impaired Driver
Robert B. Harris
Nothing to Disclose
AACT Career Lectureship
William Banner
Sherwin Williams, Doe Run Inc., Legal Consultant
AACT Scientific Symposium
Daliah Heller
Nothing to Disclose
Mark Kinzly
Nothing to Disclose
Alexander Walley
Nothing to Disclose
Daniel Wermeling
AntiOp, Inc., Owner
Leo Beletsky
Nothing to disclose
PEC: Key Messages and Core Functions of U.S. Poison Center
Alexa Steverson
Nothing to Disclose
Wendy Stephan
Nothing to Disclose
ACMT Fellows-in-Training Luncheon
GeraldLeikin
Nothing to Disclose
CAPCC Symposium:
Shaun Hosein
Nothing to Disclose
Mark Kirk
Nothing to Disclose
Susan Gorman
Nothing to Disclose
SIM Teaching Lab
CAE Healthcare METI Division is supplying the use of a high-fidelity simulator for the 3 days of the course. Neither organizers nor AACT are
receiving any direct financial support from CAE Healthcare other than provision of the simulator and supplies used on the simulator. Unless
otherwise noted, faculties teaching the simulation sessions have no financial disclosures with CAE Healthcare nor are they receiving any
financial compensation.
Jeffrey Holmes
Nothing to Disclose
Richard W Low II BA
Nothing to Disclose
AACT Fellow's Abstract Platform Session
Jolene Okaneku
Nothing to Disclose
Maude St-Onge
Nothing to Disclose
\Katherine Welker
Nothing to Disclose
Landen Rentmeester
Nothing to Disclose
Nothing to Disclose
Chris Lim
PEC: Unlocking the Silent Support of Poison Centers in a Funding Crisis
Richard W Low II BA
Carol DesLauriers
Dennis O'Sullivan
Randy Skoglund
Janetta Iwanicki
Kalana Prasad Maduwage
Sean Bush
Elizabeth Grossart
David Vearrier
Previous
Nothing to Disclose
Nothing to Disclose
America's Health Insurance Plans American College of Radiology Metropolitan
Chicago Healthcare Council, Consultant
Platform Session II
Nothing to Disclose
Nothing to Disclose
BTG Inc. Paid speaker
Nothing to Disclose
AACT Occupational Interactive Studies in Public Health Symposium
Nothing to Disclose
Liz Barta
Liz Barta
Theodore Cummins
Kristin Wenger
Jou-Fang Deng
Winai Wananukul
Ashish Bhalla
Reza Afshari
Anna Dulaney
Kapil Sharma
Greene Shepherd
Tina Wismer
Jon Cole
Jan Scaglione
Ahna Brutlag
Relevant Financial Relationship to Commercial Interests
PEC: Educator Research Award: Outreach to School Nurses
Nothing to Disclose
PEC: Swap & Share
Nothing to Disclose
October 21, 2014
ACMT Scientific Symposium:
Nothing to Disclose
PEC: Distance Learning Nuts and Bolts: How to Conduct a Webinar
Nothing to Disclose
APAMT Symposium
Nothing to Disclose
Nothing to Disclose
ASTRA ZANECA, Paid speaker
Pending
AACT Articles You May Have Missed
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
AAPCCC Veterinary Symposium
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Pet Poison Helpline/SafetyCall ,International poison center, Full-time employee
Donna Mensching
Paul Starr
Nothing to Disclose
Nothing to Disclose
PEC: MADD Using Proven Education Methods to Reduce Underage Alcohol Use
Sunny Wall
Nothing to Disclose
Toxicological Historical Society
Anthony Tomassoni
Nothing to Disclose
Mark Laubacher
Nothing to Disclose
Public Educators Symposium
Erin DeLaune
Nothing to Disclose
Luanne White
Nothing to Disclose
Wendy Stephan
Nothing to Disclose
AACT SIG Radiation Safety/WMD Symposium
Ronald Goans
Nothing to Disclose
SPI Clinical Symposium: Emerging Drugs of Abuse: Finding the Reality Beneath the Headline
Tamas Peberdy
Nothing to Disclose
AACT Acute and Intensive Care Symposium
Robert Bassett
Nothing to Disclose
Jakub Furmaga
Nothing to Disclose
PEC: The Art of Presentation: How to Address Education Barriers and Audience Segmentation
Jennifer Watson
Nothing to Disclose
Charise Thomason
Nothing to Disclose
Mike Yudizky
Nothing to Disclose
SPI Best Practices Symposium: NACCT 2014 Button Battery Ingestion
Frederick Henretig
Nothing to Disclose
Home
Next
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
NORTH AMERICAN CONGRESS
OF CLINICAL TOXICOLOGY 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
THE SHERATON
NEW ORLEANS, LA
OCTOBER 17- OCTOBER 21, 2014
Relevant Financial Relationship to Commercial Interests
Nothing to Disclose
Platform Session III
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Evik Diagnostics, Evik has been contracted to produce the first prototype of the
formate strips. I have no relationship with them except for this. Patent pending
for the presented product; the inventors have given all potential future income
to an ideal non-for profit funding for research and support of methanol
poisoning outbreaks
SPI Roundtable: Colchicine: Treatment Fit for a King
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Toxicology Newshour
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Nothing to Disclose
Toby Litovitz
Rita McKeever
Michael Hodgman
Joseph Henry Yanta
Knut Erik Hovda
Randy Badillo
Joanne Masur
Sophie Gosselin
Anthony Pizon
Stephanie Lynn
Greene Sheperd
Alexander Garrard
Janetta Iwanicki
Lewis Nelson
A.Kaye
David Juurlink
Planning Committee Disclosure of Commercial Affiliations
Member Name
NACCT Planning Committee
Karen Simone
Jay Schauben
Kennon Heard
Reza Afshari
Lewis Nelson
Martin Laliberte
Simon Thomas
Mark Winter
Bryan Hayes
Kirk Cumpston
Rob Palmer
Alexa Steverson
Wendy Stephan
Lynn Ballentine
Kathleen Anderson
Jeffrey Brent
Kristina Hamm
Previous
Relationships with commercial supporters of course
Member Name
Debra Kent
Edward Krenzelok
Rutherfoord Rose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Relationships with commercial supporters of course
Alfred Aleguas Jr
Adam Pomerleau
Diane Calello
Randall Gadillo
Tamas Peredy
Frederick Henretig
Jeffrey Suchard
Bruce Anderson
Ziad Kazzi
Jenny Lu
Joseph D’Orazio
Steven Aks
Louise Kao
Bryan Judge
CC Yang
Greene Sheppherd
Suzanne White
Ayrn O’Connor
Christina Hantch-Bardsley
Lori Salinger
Jaime Cook
Kristie Williams
Diane Calello
NACCT Symposia Organizers
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Johnson & Johnson (McNeil) Mylan Pharmaceuticals, Consultant
Nothing to disclose
McNeil, BTG, Cumberland; contracts with RMPDC for consulting and research; no direct financial
ties
Pending
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Nothing to disclose
Home
Next
The AAPCC Public Education
Committee (PEC) Presents:
NACCT 2014 Education Track
“Assess. Achieve. Advance.”
Educators welcome all poison center staff
to participate in PEC sessions. Together, we
can improve the public’s understanding of
poison centers and poison safety .
See the
NACCT
schedule
for PEC
session
details!
2015
SAVE THE DATE
OCTOBER 8-1 2
HYATT REGENCY SAN FR ANC I S CO
North American Congress
of Clinical Toxicology
Organized By The American Academy of Clinical Toxicology
2014 PEC sessions include:
SAN FRANCISCO • October 8-12, 2015
A Harm Reduction Approach to
Injury Prevention: Naloxone Rescue
Kits in the Community
Sunday, 10:30-11:30am
Unlocking the Silent Support of
Poison Centers in a Funding Crisis
Monday 1-2:30pm
Promoting Food Safety:
Surveillance, Partnerships, and
Education
Tuesday, 1-2:30pm
Medical,
nursing,
pharmacy
credits
available
Previous
Sponsored By:
• American Academy of Clinical Toxicology
• American Association of Poison Control Centers
Annual Meeting of:
• American Academy of Clinical Toxicology
• American Association of Poison Control Centers
• American College of Medical Toxicology
• Canadian Association of Poison Control Centres
• European Association of Poisons Centres and Clinical Toxicologists
Home